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Abstract 
The vitamin biotin plays an important role as a cofactor for carboxylation enzymes involved 
in a variety of metabolic processes. It is known that biotin biosynthesis in micro-organisms 
and plants occurs via a similar biosynthetic pathway, while mammalian biotin is produced by 
gut micro-flora. The initial steps in the biotin biosynthetic pathway are therefore important 
targets for the development of potential herbicides. 
The requirement for this work was the development of a short and versatile route to a-
aminoketones as potential substrates and inhibitors of the enzyme 7,8-diaminononanoate 
synthase (DANS). This is the second enzyme in biotin biosynthetic pathway, and uses the a-
aminoketone 8-amino-7-oxononanoate (AON) as its substrate. a-Aminoketones are 
important intermediates in a number of other important biosynthetic pathways, and as a 
result a number of synthetic strategies have previously been developed. Here we describe the 
development of two routes to AON using the Dakin-West reaction and the mtroaldol 
reaction. 
Condensation of an acid chloride with an oxazolone gives rise to the 0-acyloxyoxazole 
which can be isomerised to its more thermodynamically stable C-acyl oxazolone isomer. 
Ring opening and deprotection of this species gives the required a-aminoketone via the 
dakin-West reaction. Initial nitroaldol condensation of a mtroalkane and an aldehyde affords 
the required nitroalcohol, which can be easily oxidised to the nitroketone. Hydrogenation 
affords the a-aminoketone as its hydrochloride salt. 
The nitroaldol reaction is advantageous as it is not only short but allows variation in both 
chain length and substitution, thus providing an accessible route to a variety of a-
aminoketone derivatives in good yield. 
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Chapter 1 	 Introduction 
1.1 An Introduction to Biotin 
The early twentieth century saw the discovery of a large number of enzyme cofactors. Amongst 
these was biotin., a water soluble cofactor discovered from three parallel fields of research. In 
1901 Wildiers' discovered that bios, a material derived from beer wort, stimulated the growth 
of yeasts. It was later discovered that his "bios" was a mixture of biotin, alanine and pantothenic 
acid 2 . In the 1930s Burk described coenzyme R 3, a compound necessary for the growth of 
Rhizobium, a nitrogen fixing bacteria, which was later discovered to be identical to biotin ". At 
the same time three groups were conducting research into a substance protecting animals from 
the fatal effects of ingesting raw egg whites. Boas called this "protective factor x", while 
Gyorky used "vitamin H" and Williams "the protective factor against egg white injury", it has 
since been realised that all of these factors were also identical to biotin 6. It is now known that 
biotin is an essential vitamin for all mammals, and is produced in minute quantities by plants, 
bacteria and yeasts. It is thought that concentrations in bacteria are never more than nanomolar , 
whilst in plant mesophyll cells the biotin concentration can reach 11 AM 8 .  
1.1.1 Structure of Biotin 
[1] 
Figure 1.1: D-(+)-Biotin 
Biotin (Figure 1.1) was first isolated by as its methyl ester by Kogl and TOnnis in 1935, its 
structure was determined by du Vigneaud in 194210  and was confirmed by the first total 
synthesis by Harris in 194411.  X-ray studies have shown biotin to have an imidazolidone ring 
cis-fused to a tetrahydrothiophene ring with a valerie acid side chain at the C-2 position. Biotin 
contains three asymmetric carbons and therefore has eight stereochemical forms, although only 
one form, (+)-biotin (1, Figure 1. 1), is biologically active. 




1.1.2 Biotin as a Cofactor 
It was suggested that biotin may play a role in carbon dioxide fixation as early as 1943 12,  and 
experimental evidence was found to support this in 1953 13  A study by Wakil' 4 showed biotin 
to be an essential component of the acetyl CoA carboxylase enzyme and the central role of 
biotin in carboxylation reactions was revealed. To act as a mobile carrier of activated carbon 
dioxide biotin must be bound to the biotin carboxyl carrier protein (BCCP, Figure 1.2). BCCP is 
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Figure 1.2: Biotin linked to the Biotin Carboxyl Carrier Protein (BCCP) 
group of a lysine residue. The flexible chain linking biotin to the BCCP enables the biotin group 
to swing between the two catalytic domains of the carboxylase enzyme, facilitating the transfer 
of the carboxyl group between the donor and acceptor sites. Biotin acts as a carboxyl carrier for 
three distinct categories of enzymes, as outlined below. 
1.1.2.1 Class I: Carboxylase Enzymes 
Enz-biotin + ATP + HC0:3 	
Mg2 	
Enz-biotin-0O2 + ADP + p04 3- + H 
Enz-biotin-CO + R-H 	 Enz-biotin + R-COi 
Scheme 1.1: Partial reactions for Class I biotin dependant carboxylases 
In class I carboxylase enzymes biotin mediates the transfer of a carboxylate group from 
hydrogen carbonate to acceptor molecules such as pyruvate, propionyl CoA, acetyl CoA, 1 3-
methylcrotonyl CoA, geranyl CoA and urea. The reaction takes place in two reversible steps as 
shown in Scheme 1.1. The initial step in the sequence is the adenosine 5 '-triphosphate (ATP) 
dependant formation of the carboxy-biotin intermediate. Formation of the carboxy-biotin 
complex activates the carboxyl group allowing the transfer of CO 2 without additional energy 
input. 




1.1.2.2 Class ti: Decarboxylase Enzymes 
Enz-biotin + R-0O2 	 Enz-biotin-0O2 + R-H 
Enz.biotin-0O2 + 2(Na') 	 Enz-biotin + HCO3 + 2(Na+),ut  
Scheme 1.2: Partial reactions for Class II biotin dependant decaboxylases 
Class II decarboxylase enzymes regulate the transport of sodium ions in anaerobes, and are 
linked to the decarboxylation of 3-keto acids and their thioesters, such as oxaloacetate, 
methylmalonyl CoA and glutaconyl CoA. In this case ATP is not required and "active" CO 2 is 
transferred directly from the keto acid to the biotin containing enzyme (see Scheme 1.2). 
1.1.2.3 Class Ill: Transcarboxylase Enzymes 
Enz-biotin + oxaloacetate 	 4 	 No. 	Enz-biotin-0O2 + pyruvate 
Enz-biotin-0O2 + prpionyl-CoA 	I 	 10 	Enz-biotin + methylmalonyl-00A 
Scheme 1.3: Partial reactions for Class Ill biotin dependant transcarboxylases 
The only known class III transcarboxylase enzyme is methylmalonyl CoA: pyruvate 
carboxytransferase, which mediates the formation of methylmalonyl CoA from oxaloacteate in 
Propionibacterium shermanii. As in the case of class II enzymes this reaction does not require 
ATP, and the CO2 moiety is transferred directly from an acyl derivative to the biotin containing 
enzyme (see Scheme 1.3). 
1.1.3 Mechanism of Biotin Carboxylation 
The first indication of the mechanism of biotin carboxylation came from work by Lynen in 1959 
15  He found that -methylcrotonyl CoA carboxylase, in the presence of ATP and Mg 2 , 
catalysed the carboxylation of free (+)-biotin. Diazomethane trapping of the enzymatic reaction 
intermediate recovered the dimethyl ester of 1'-N-carboxy-biotin (3, Figure 1.3), indicating 
carboxylation at the 1'-N position on biotin. This was confirmed by x-ray analysis of the bis-p-
bromoanilide derivative of carboxybiotin by Bonnemere in 196516 
It was suggested that since N-carboxybiotin is apparently chemically inert, the active enzymatic 
species could be 0-carboxybiotin 17,  which might rearrange to the more stable N-acyl compound 
during trapping and isolation. Although attractive, this theory was disproved when it was found 
that synthetic 1 '-N-carboxybiotin was a chemically and kinetically competent substrate for 
acetyl CoA carboxylase' 8 
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Figure 1.3: 1 '-N-Carboxybiotin (2) and dimethyl-1 '-N-carboxybiotin (3) 
Tracer experiments were used to investigate the carboxyl substrate for the carboxylation of 
biotin' 9.Using [' 803]-bicarbonate as the substrate for the propionyl carboxylase reaction Kaziro 
found that two 1 8  0 atoms were incorporated in the carboxyl group of methyl malonyl-CoA 
CoA, and the third in the phosphate group released from ATP. Although this strongly suggested 
that the bicarbonate ion was the true substrate it did not rule out dehydration to carbon dioxide 
in the enzyme active site, however it was also shown that the bicarbonate ion was directly 
involved in the cleavage of the f3—y Mg-ATP bond. 
There have been a large number of mechanistic pathways proposed for the carboxylation of 
biotin. However only three are mechanistically attractive, these are shown in Figure 1.4. 
Pathway A 
Yq( 
ATP Biotin r 
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Figure 1.4: Three Proposed Mechanisms for the carboxylation of biotin 
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Kaziro' 9 proposed that the bicarbonate ion was preactivated by ATP (Pathway A) forming the 
carboxyphosphate intermediate (4). This could then react directly with biotin to form 1 '-N-
carboxybiotin (2) as shown in (a), or decompose to enzyme bound CO 2 and carboxylate biotin 
as shown in(b) 20 . 
In 1967 Lynen 2 ' proposed biotin was pre-activated by phosphoiylation of the urea oxygen. The 
resultant O-phosphobiotm (5) could then react with bicarbonate in a concerted six-electron 
pericycic reaction to form (2), as shown in Pathway B. 
Pathway C was proposed by Kiuger in 197922  and also involves the pre-activation of biotin to 
form O-phosphobiotm (5). In this route (5) is attacked by a bicarbonate ion to form the 
carboxyphosphate (4) and the iniidazolidone anion of biotin (6). Kiuger suggested that (4) and 
(6) react, possibly with pre-formation of CO 2 to form carboxybiotin (2). 
It has been demonstrated that enzymatic displacements at phosphorus centres take place with 
"in-line" geometry, and inversion of stereochenidstry 23 This implies that Pathways A and B, 
Figure 1.4, would result in inversion of configuration, while Pathway C would have an overall 
retention of configuration. To find the true mechanism of biotin carboxylation Hansen and 
Knowles used the [y- 170, 7- 180]-y-phosphorothioate of ATP, a chiral ATP analogue, as the 
substrate for the pyruvate carboxylase enzyme. It was found that the reaction product, [ 160 170, 
180]-thiophosphate had overall inversion of stereochemistry at the phosphorus centre, thus 
ruling out Pathway C. 
Incubation studies showed that biotin carboxylase could produce ATP from Mg-ADP and 
carbamoyl phosphate 24,  thus supporting the involvement of a carboxyphosphate (4) in the 
reaction mechanism, and indicating Pathway A as the most likely reaction mechanism. Despite 
the initial thought that the imidazolidone nitrogen would not act as a nulceophile, this is now 
considered to be the most probable pathway 25.  
Despite much research on the mechanism of biotin carboxylation none of the proposed 
mechanisms have been completely experimentally verified. This is primarily due to problems 
performing reliable isotope exchange experiments on reversible processes and the failure to trap 
any of the putative intermediates. 
Mhain I. Brunton 	 August 2003 
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1.1.4 Mechanism of Carboxyl Transfer 
In their study on propionyl CoA carboxylase Retey and Lynen 26 found that carboxylation 
proceeded with retention of configuration at the carbon accepting the carboxyl group. They also 
found that proton exchange between the substrate and solvent only occurred with enzymatic 
turnover. This lead them to propose a concerted pericyclic mechanism for carboxyl transfer, as 
shown in Pathway 1, Figure 1.5. 
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Figure 1.5: Proposed mechanisms for carboxyl group transfer 
The unprecedented nature of the mechanism in pathway 1 prompted further study in the area. In 
their work on the same enzyme Stubbe and Abeles 27 found that HF was eliminated when 
13-fluoropropionyl-CoA was used as a substrate. This led them to suggest a stepwise mechanism 
and the involvement of a carbanion intermediate, as shown in pathway 2, Figure 1.5. Knowles 25 
proposed a third mechanism, pathway 3, Figure 1. 5, based on kinetic studies by Sauers 20. This 
is similar to pathway 2, but Knowles suggests that decarboxylation occurs prior to substrate 
carbariion attack. 
Knowles and O'Keefe 28  and Attwood 29 confirmed a stepwise mechanism for the carboxyl 
transfer in their work identifying the rate determining steps in transcarboxylase and pyruvate 
carboxylase respectively. Knowles and O'Keefe compared the kinetic isotope effect of [' 3CD31- 





pyruvate and [ 13CH3]-pyruvate as substrates for the transcarboxylase enzyme. In a concerted 
reaction the rate would be slowed by deuterium substitution, but the ' 3C effect would be 
unchanged. If the reaction were to proceed in a stepwise fashion it would be expected that 
deuterium substitution would slow deprotonation and carboxylation would become less rate 
limiting, therefore lowering the ' 3C effect. The results of their studies showed a lowering of the 
' 3C effect, substantiating a stepwise mechanism. The investigations on pyruvate carboxylase by 
Attwood found a similar result. 
1.1.5 Biotin Binding Proteins 
There are several proteins known to bind biotin, with the most well known being the egg white 
glycoprotein avidin and streptavidin, isolated from Sireptomyces avidinii. Avidin and 
streptavidin are homotetrameric 70kDa proteins. Each subunit is folded into an eight stranded 
anti-parallel 13-barrel, binding biotin at one end between two tryptophan residues. The biotin-
avidin interaction is one of the strongest protein-ligand interactions known (K d= iO' M), and 
the complex can withstand extremes of pH, buffer salts and chaotrophic agents such as 
guanidine 30 . This has provided researchers with a valuable tool for use in a variety of 
biochemical and immunological studies. 
1.1.6 Effects of Biotin Deficiency 
Biotin deficiency in mammals occurs as the result of prolonged antibiotic treatment destroying 
gut microflora, the main producer of biotin, or from excessive ingestion of raw egg whites. A 
shortage of biotin reduces the activity of biotin dependant enzymes and indirectly results in 
impairment of lipid and protein synthesis and inhibition of RNA synthesis. The physiological 
effect of biotin deficiency in mammals can include dermatitis, alopecia, skin lesions, and 
nausea, however the symptoms are relieved by a dietary supplement of biotin. 
1.2 Biotin Biosynthesis: an overview 
1.2.1 The E.coIi Biotin Operon 
Biotin biosynthesis in Escherichia coil (E. coil) is controlled by the genes encoded in the 5.8 
kilobase biotin (blo) operon, located at 17 minutes on the E. co/i genome, between the 
attachment site of the lambda prophage (atlA) and the uvrB gene 3 1 . Complementation analysis 
of biotin mutants showed the No operon to consist of five genes: bioA; bioB; bloC; bioD and 
Mhain I. Brunton 	 August 2003 
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bioF, coding for the principle enzymes in biotin biosynthesis 32,33  Deletion mapping was used to 
establish the gene order of the operon 34,35  , and on locating the position of the operator and 
promoter it was concluded that the operon was divergently transcribed 36  (see Figure 1.6). The 
promoter/operator is located between the bioA and bioB genes, and is transcribed to the left into 
bioA and to the right into bioFCD and B. 
I Okb 	 I 6kb 
ORFII 	A I 	I 	B 	I 	F 	I 	C 	I 	D 
BFCD 
	
I Promoter/Operator 	I 
Figure 1.6: The E.coli biotin operon 
In addition to the genes found in the bio operon, there are three genes located at separate 
locations on the E.coli genetic map. The gene bioH has been found at 74 minutes on the E.coli 
genome 37,  and although little is known about its function, current evidence suggests that bioH 
may be an acyl carrier protein 38 Eisenberg identified two other genes: bioP, a permeability 
gene; and bioR, a regulatory gene it has since been discovered that this is identical to the birA 
gene discovered by Barker and Campbell 40. 
1.2.2 Regulation of the Biotin Operon in E.coIi 
Pai and Lichstein first showed evidence for the control of biotin biosynthesis in E.coli in 1965 
41  It was found that biotin production decreased with increasing biotin concentrations in the 
growth media, and it was later discovered that this was due to repression rather than to feedback 
inhiti 42 It is now known that the protein BIrA, product of the bioR gene, is the controlling 
factor in biotin biosynthesis. 
BirA is a 321 amino acid (35.3 kDa) bifunctional protein, acting as a biotin activating enzyme 
and a transcriptional regulator 43 . Activation of biotin is necessary for ligation to the BCCP and 
is achieved by the formation of biotinyl-AMP using ATP. This proceeds via a BirA-biotinyl-
AMP intermediate, which can act as a co-repressor, binding to the 40 base-pair blo operator and 
repressing transcription of the biotin biosynthetic genes. BirA therefore synthesises its own co-
repressor, a unique property amongst DNA binding proteins. 







1.2.3 Biotin Biosynthetic Pathway 
It took nearly twenty years from the discovery of the role of biotin in cell biochemistry to 
elucidate the biotin biosynthetic pathway in E. coli. The route (Figure 1.7) is now known to be 
ubiquitous using similar enzymes in bacteria, fungi, and higher plants 45, as shown below. 
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Figure 1.7: Biotin Biosynthetic Pathway 
The first step in the pathway is the decarboxylative condensation of L-alanine and pimeloyl-
CoA (7) to produce 8-amino-7-oxo nonanoate (AON, 8). This is catalysed by the pyridoxal-5'-
phosphate (PLP) dependant bioF gene product, 8-amino-7-oxo nonanoate synthase (AONS). 
AON is converted to 7,8-dianiino nonanoate (DAN, 9) in a transamination reaction mediated by 
the bioA gene product, diaminononanoate synthetase (DANS) another PLP dependant enzyme. 
Formation of dethiobiotin (DTB, 10) is the result of carbonyl insertion in DAN catalysed by the 
bioD gene product dethiobiotin synthetase (DTBS). The final step in the biosynthetic pathway is 
the insertion of a sulfur atom into DTB, catalysed by the bioB gene product biotin synthase, 
yielding biotin (1). 
Mhain I. Brunton 	 August 2003 
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1.3 Enzymes involved in Ecoli Biotin Biosynthesis 
1.3.1 Pimeloyl-00A Synthesis 
The initial step in biotin biosynthesis in any organism is the formation of pimeloyl-CoA, 
however the synthesis varies between different bacterial and plant hosts. In B.sphaericus and 
some plants the No  gene has been found to encode a pimeloyl-CoA synthetase enzyme 46,47 
The B.sphaericus protein is a homodimer with subunit mass of 28kDa, catalysing the reaction of 
pimelic acid and HSCoA, in the presence of ATP and Mg 2 to form pimeloyl-CoA and 
pyrophosphate. 
There is no gene equivalent to bloW in E.coli. However 13C labelling studies have prompted 
Sanyal and Ifuku to propose that pimeloyl-CoA in E.coli is produced in a pathway similar to 
that of fatty acid and polyketide synthesis 48,49,  The suggestion that pimeloyl-CoA is produced 
from malonyl-00A starter units supports the findings of Lynen 5° who postulated that pimeloyl-
CoA was synthesised from the condensation of three malonyl-00A molecules. Although E.coli 
does not have the No  gene it does have two other genes: bloC and bioH, which have been 
implicated in pinieloyl-CoA synthesis. Lemoine and co-workers have suggested that the bloC 
gene product may act as an acyl carrier protein, catalysing the stepwise condensation of 
malonyl-CoA starter units by the addition of acetate groups in a pathway similar to that used in 
chalcone synthase 311  . The same group have also proposed that the bioH gene product transfers 
the pimeloyl moiety from an active cysteinyl residue on the bioC protein to HSCoA, preventing 
the accumulation of free pimelate in the cell. Studies on bioH in our laboratoiy 51 have found 
that 99% of the over-expressed and purified protein has the expected mass of 28,502 Da. E.coli 
B1oH was incubated with CoA, M902  and DU and analysed by LC-MS. The spectra showed a 
peak at 28,506 Da corresponding to unmodified BioH, but also two additional peaks were found 
at 28,849 Da and 29,272 Da. The peak at 29,272 Da corresponds to an addition of 765 Da, the 
mass of a HSCoA molecule, however the peak at 28,849 Da represents an addition of 343 Da, 
and is as yet unidentified. These results combined with genetic complementation analysis and 
enzymatic assays have lead Tomczyk et alto suggest that BioH may act as a CoA donor to a 
pimeloyl-ACP or a condensing enzyme. 









Alanine 	 PimeIol CoA [7] 	 AON (8] 
Figure 1.8: Formation of AON from Alanine and Pimeloyl-00A using AONS 
8-Amino-7-oxononanoate synthase (AONS) is the product of the bioF gene, and catalyses the 
decarboxylative condensation of pimeloyl-CoA (7) and L-alanine to produce AON (8) using a 
PLP co-factor. Eisenberg and co-workers purified AONS in the 1970's 42, but the sequence of 
the E. coli bioF gene was not established until 1988 52  The bioF gene has also been cloned from 
B. sphaericus and over-expressed in E. coli and preliminary data for the crystallised enzyme 
published. Work in our laboratory has determined the structure 55 and mechanism 56  of the 
E.coli AONS. 
Figure 1.9: Crystal structure of AONS 
The crystal structure of E.coIi AONS (see Figure 1.9) has revealed that the enzyme functions as 
a homodimer, with each monomer having a mass of 41,464 Da, containing three separate 
domains. The small N-terminal domain (turquoise) acts as a linker, wrapping around the 
opposing monomer. The N-terminal domain is linked to the large central domain (purple), 





which is composed of a seven stranded n-sheet, flanked by two cc-helices, and curved around 
two more. This is in turn linked to the small (approximately 100 residues) C-terminal domain 
(yellow). 
Each monomer of E.coii AONS contains an active site, located within a deep cleft between the 
central and C-terminal domains, and using amino acid residues form both monomers. The PLP 
binding residue is lysine-236, inside the active site cleft, and therefore allows space for the 
pantothenoyl arm of pimeloyl-CoA to bind. Analysis of the holoenzyme structure has shown 
that PLP binding induces a conformational change. On formation of the internal aldimine a 
histidine (14133) residue to moves to lie in parallel with the pyridine ring of PLP, creating 
important it-interactions. A further conformational change occurs on product binding, in this 
instance the pyridine ring of PLP rotates approximately 15° with respect to the position of the 
internal aldimine. Product binding also causes the final turn in the C-terminal helix to unwind, 
causing the tip of the domain to move and imitate a lid closing on the external product aldimine. 
Kinetic and spectroscopic studies on E coil AONS have suggested a mechanistically attractive 
pathway for the formation of AON (see Figure 1.1056)  The initial step in the pathway is 
displacement of the AONS-PLP internal aldimine by the attack of L-alanine (Step 1). This 
causes displacement of the Lysine-236 from AONS and formation of the external aldimine by 
transimination of L-alanine. The entry of pimeloyl-CoA into the active site (Step 2) induces a 
conformational change, allowing abstraction of the a-proton from the external aldimine. This 
results in the formation of a quinonoid intermediate (Step 3), which attacks pimeloyl-CoA, 
releasing CoA and forming a new carbon-carbon bond (Step 4). Loss of the carboxyl group 
from L-alanine results in the formation of a second quinonoid intermediate (Step 5), which 
picks up a proton from the positively charged lysine-236 residue (Step 6). The final step in the 
mechanism (Step 7) is transmiination by the basic lysine-236 residue reforming the original 
internal aldimine and releasing AON (8). 
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Figure 1.10: Mechanism of AON formation 
Structural and mechanistic studies have revealed that AONS belongs to the a-oxoamine 
synthase family of enzymes 57 .  These PLP dependant enzymes catalyse the decarboxylative 
condensation of an amino acid and a CoA thioester to form an a-aminoketone. The other 
enzymes in this group are: 5-aminolaevulinic acid synthase (ALAS), catalysing the 
condensation of glycine and succinyl-00A to form 5-aminolaevulinic acid, an intermediate  used 
in the initial stages of haem biosynthesis 58;  serine palmitoyl transferase (SPT), a membrane 
bound protein involved in sphingolipid biosynthesis, which catalyses the condensation of 
palmitoyl-CoA and serine to form 3-ketodihydrosphingosine 59;  and 2-amino-3-ketobutyrate 
CoA ligase (KBL), catalysing the reaction of acetyl-CoA and glycine to form 2-amino-3-
ketobutyrate, used in threonine biosynthesis 60 .  
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Figure 1.11: Formation of DAN from AON using DANS 
The formation of 7,8-diaminononanaote (DAN, 9) from AON is catalysed by the bioA gene 
product, 7,8-diaminononanoate synthetase (DANS). DANS has an absolute requirement for 
PLP, and is unique amongst amino-transferases, catalysing the stereospecific transfer of the 
amino group from S-adenosyl methionine (SAM) to the re face of AON. It was originally 
thought that methionine acted as the amino donor 61 , however it was subsequently shown that 
SAM was the true amino donor 62 . 
Figure 1.12: Crystal Structure of DANS 
Eisenberg and Stoner purified DANS to 86% homogeneity in 1975 63,  and found that the protein 
was a dimer with a subunit mass of approximately 47 kDa, and an iso-electric point of 4.7. The 
dimeric structure of DANS (see Figure 1.12) was confirmed in 1999 with the publication of the 
crystal structure of the enzyme 64 . It was revealed that each dimer consisted of two domains, a 
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small domain, comprised of the N and C-terminal regions (turquoise and yellow respectively), 
split by a larger (central) domain. This large domain is made up of a 7-stranded 13-sheet, 
surrounded by a-helices. Each monomer contains two structural sodium atoms, shown in blue. 
The DANS active site is located in a cleft formed by both the large and small domains of one 
monomer, but also uses amino acid residues from the other subunit. The PLP cofactor forms an 
external aldimine with the lysine-274 residue, located at the bottom of the cleft. AON binds 
with its polar head towards the cofactor and its acid tail close to the entrance of the cleft 65 . 
S-adenosylmethionine 	 DANS-PLP ,.i 7,8-Diaminononanoate 
(SAM) 	 (DAN) 
, S-adenosyl-2-oxo- 
4-methyithiobutyric? 	 DANS-PMP 	 8-Amino-7-oxononanoate 
acid 	 (AON) 
Figure 1.13: Ping-pong transfer of amino group from SAM to AON 
The absolute requirement of PLP by DANS puts it in the family of vitamin-13 6-depenant 
aminotransferases 63 whose mechanism of action is well established 66,67.  In the case of DANS 
the transfer of the SAM amino group to AON occurs via a ping-pong mechanism (see Figure 
1. 13) 12,61 .  In first half of the reaction the internal PLP-DANS aldimine is displaced by the 
formation of the SAM-PLP external aldimine, this is converted to the DANS-pyridoxamine 
phosphate (DANS-PMP) form, and the putative product S-adenosyl-2-oxo-4-methylthiobutyric 
acid leaves the active site. This speculative reaction product has never been isolated from 
enzymatic incubations, and it is suggested that it may readily decompose to 5'-
methylthioadensoine and 2-oxo-3-butenoic acid under non-enzymatic conditions 63 . The second 
half reaction begins with binding of AON to the active site, this receives the amino group from 
DANS-PMP, to form DAN and regenerate the DANS-PLP internal aldimine. 
It has been suggested that the bioA and bioF genes could be derived from a common ancestral 
gene 68' as the two gene products share a number of similar features including substrate 
specificity and requirement of the same PLP cofactor. Otsuka 52 showed that AONS and DANS 
shared a 20% amino acid homology, and the binding sites for both PLP and adenosyl derivative 
binding sites are found in similar positions. Despite this similarity it is noteworthy that DANS 
shares homology with other a-aminotransferases and AONS with other a-oxoamine synthases. 














Figure 1.14: Formation of DTBS from DAN using DTBS 
The bioD gene product, dethiobiotin synthetase (DTBS), catalyses the formation of the 
imidazolidone ring of biotin, converting DAN into dethiobiotin (DTB, see Figure 1.14). It is 
interesting to note that DTBS is one of the few CO 2 utilising enzymes that does not involve a 
biotin prosthetic group. 
Much of the early work on DTBS were carried out by Eisenberg and Krell who revealed the 
substrate-product relationship between DAN and DTB 69, and established the requirement for 
CO2. Mg2 and ATP 70. Eisenberg and Krell subsequently purified DTBS to near homogeneity 
and showed the active form of the enzyme to be a homodimer with a molecular weight of 
approximately 42 kDa 71 . The genetic sequence was deduced by Otsuka 52 and later corrected by 
Alexeev 72 	found that DTBS was a 224 amino acid protein with the N-terminal methiomne 
residue cleaved by a post translational process. 
Figure 1.15: Structure of DTBS dimer 





The homodimeric nature of E.coli DTBS was confirmed when the crystal structure of the 
enzyme was solved independently by two groups 73' Each DTBS monomer (see Figure 
1.15)consists of one subunit folded as an a113-domain, containing a central seven-stranded 
parallel 13-sheet shown in blue surrounded by a-helices shown in yellow. The active site of the 
enzyme is located within a concave space at the interface of the two monomers, with the 
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Figure 1.16: Mechanism of amino-carbamate formation 
Krell and Eisenberg 71  used 8-' 4C-ATP as a substrate for the DTBS reaction to determine the 
stoichiometric relationship between ATP and DTB. They found that adenosine cliphosphate 
(ADP) and DTB were formed in equimolar quantities from DAN and DTBS. The overall 
stoichiometry of the reaction was established by Baxter el a1 76 who found that one mole of ATP 
was required to from 1 mole of DTB, thus indicating a single activation step for the formation 
of two amide bonds. In the course of this work radiolabel pulse chase experiments revealed that 
the first step in the DTBS catalysed reaction was amino-carbamate formation. By trapping this 
intermediate using diazomethane Baxter and co-workers suggested that the initial amide bond 
was formed at N-8 on DAN resulting in the 8-amino-carbamate (11, Figure 1.16). Analysis of 
the enzyme-DAN-carbamate crystal structure by Huang el a1 74 and Alexeev et a1 75 
subsequently found that the true intermediate was the 7-amino-carbamate (12, Figure 1.16). 
Further work by Gibson 77  isolated four times as much 7-amino carbamate as 8-amino carbamate 
from diazomethane trapping mixtures of DAN, [' 4CO2], and DTBS. The conclusion of this work 
found that DTBS conferred specificity on carbamate formation, activating DAN at the 7-
position. 
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Figure 1.17: DTBS ring closure 
With the first step in the reaction mechanism established to proceed without ATP activation, 
Baxter and Baxter 78 carried out incubation studies to establish the mechanism of the ring closure 
step in the DTBS mechanism. It was known that 1 mole of ATP was converted to ADP and 
inorganic phosphate, but there were two possible reaction intermediates, a phosphoric or an 
ADP mixed anhydride (13 & 14, Figure 1.17). They incubated DTBS with 180  labelled ATP, 
DAN, bicarbonate and Mg2+ 	 18 and analysed the distribution of 0 in the products by 31  P NMR. 
From this it was revealed that the reactive intermediate formed was the carbamate-phosphoric 
mixed anhydride (13) and ring-closure followed Pathway A (Figure 1.17). 








Figure 1.18: Formation of Biotin from DTB using Biotin Synthase 
The final step in the biotin biosynthetic pathway is the insertion of sulfur into the carbon 
skeleton of DTB. This process is catalysed by the bioB gene product biotin synthase, an iron- 
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sulfur cluster containing enzyme 48 that requires an extensive number of co-factors. 
E. coil Biotin synthase is a 346 amino acid protein with a predicted mass of approximately 38.5 
kDa 52. Cloning, purification and over-expression of the bloB gene product from E.coli was first 
carried out by Sanyal 79 . Native gel electrophoresis revealed two protein species with molecular 
weights of 82 kDa and 104 kDa; both of these species gave the expected monomeric molecular 
weight of approximately 39 kDa on SDS gels. The 82 kDa species was found to be a 
homodimer containing one [2Fe-2S] cluster per monomer, while the 104 kDa species was a 
homodimer with a single [2Fe-2S] cluster. It was found that the 104 kDa species could be 
converted to the 82 kDa species by incubation with FeC1 3 (Fe 3+), Na2S (S2 ) and 2-
mercaptoethanol. EPR studies on the Fe-S cluster from the 82 kDa species confirmed the 
presence of one [21'e-2 S]cluster per monomer go . It was found that one iron ion is bonded to two 
sulfur ligands, while the other has a cysteme ligand and a terminal oxygenic ligand. Initial 
results suggested that anaerobic reduction of the dimer converts the two [2Fe-2S] clusters to one 
[4Fe-4S] cluster where each iron is bonded to a cysteine ligand, oxidation of this species results 
in partial formation of the original cluster. Recent work by 011agnier-De Choudens et al  81 
confirms that although [2Fe-25] clusters occur in the aerobic dimeric form, the anaerobic dimer 
contains two [4Fe-4S] clusters. The group has also found that in the absence of external iron and 
sulfur the anaerobic dimer contains only one [4Fe-4S] cluster, Iron-sulfur clusters can play a 
important roles in a number of different proteins, and the most probable role of the [4Fe-4S] 
cluster in biotin synthase is to act as a radical initiator, facilitating the reductive one electron 
cleavage of SAM to form methionine and a 5 '-deoxyadenosyl radical. 
In addition to the iron-sulfur cluster biotin synthase requires a number of co-factors for activity 
including: fructose-1,6-bisphosphate; SAM; Fe 2 ; reduced nicotinamide adenine dinucleotide 
phosphate NADPH); E. coil fiavodoxin; and E. coil flavodoxin NADP oxidoreductase 828379 It 
has also been suggested that there is a requirement for a thiamine pyrophosphate dependant 
enzyme, and one of the following amino acids: asparagines; aspartate; glutamine or serine . 
The investigation into the mechanism of the biotin synthase enzyme can be split into two main 
fields: the source of the sulfur donor and the mechanism of C-H to C-S bond formation. Early 
studies on the nature of the sulfur donor proved inconclusive. Recent studies undertaken by 
Shaw 85 have found that that sulfur from [35S]-cysteine can be incorporated into a reaction 
intermediate. The group of Marquet 86 has found that regeneration of the B.sphaericus biotin 
synthase cluster with FeC1 3 and Na234S results in the production of 34  S-biotin. Shaw has also 
shown that SAM is required to form an enzyme generated intermediate, which is then converted 
to biotin in another SAM dependant step. Assays using [14C-methyi] -SAM have shown that 
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[ 14C]-methionine is the product, supporting the hypothesis that SAM is cleaved to form 
methionine and a 5 '-deoxtadenosyl radical. The group proposed a mechanism where the 
conversion from DTB to the intermediate is dependant on a substrate or enzyme bound radical 
from the reductive cleavage of SAM, as is the conversion of the intermediate to biotin step. 
II 
[15] 	 (16] 	 [17] 
Figure 1.19: Proposed thiol intermediates 
Early studies on the nature of C-H to C-S bond formation by parry 87,88 found that sulfur 
introduction at C-6 and C-9 took place without loss of hydrogen at C-7, C-8 or C-5, tritium 
labelling studies revealed that sulfur incorporation involved loss of one hydrogen form both C-6 
and C-9. The synthesis of chirally tritiated dethiobiotin showed that it was the 6-pro-S-hydrogen 
was lost from the C-6 position 89 with overall retention of configuration at this centre. This 
suggests that functionalisation takes place in a single step, however both hydroxyl and thiol 
groups have been implicated as intermediates. Marquet 9° and Emoto 9 ' have found evidence 
against the formation of hydroxylated dethiobiotin intermediates, however this does not rule out 
the existence of hydroxylated dethiobiotin in a transient enzyme bound state. The presence of 6-
and 9-mercaptodethiobiotin (15 and 16, Figure 1.19) have been proposed as intermediates in the 
biotin synthase reaction by Marquet eta! 92 and Baxter eta! 93 respectively. Baxter found that 9-
mercaptodethiobiotin could support the growth of and E.coli bioA mutant (strain 6435), whilst 
Marquet found that 6-mercaptodethiobiotin could replace DTB or biotin in a biotin auxotrophic 
strain of B.sphaericus. Biological evaluation of both compounds with resting cells of 
B.sphaericus has found that 9-mercaptodethiobiotin is transformed to biotin with a 10% 
conversion rate compared to DTB. Incubation of S-(17) of the same cells in the presence of 
DTT has clearly shown the conversion of (17) into biotin, with no observed degradation. This 
has been substantiated by the identification of (17) as an intermediate in the biotin biosynthetic 
pathway in Lavendula vera 8 





1.4 Pyridoxal Phosphate Enzymes involved in Biotin 
Biosynthesis 
1.4.1 Pyridoxal-5'-Phosphate Dependant Enzymes 
The vitamin B 6 (18, Figure 1.20) derived cofactor pyridoxal-5'-phosphate (PLP, 19) is used by a 
great many enzymes catalysing transformations at the a-, -, or y-carbons of amino acids or 
other important amino containing compounds. The biotin biosynthetic pathway contains two 
enzymes catalysing PLP dependant transformations at a-carbon centres (see sections 1.3.2 and 
1.3.3 on AONS and DANS). 
RCO2 
OH OH 
(_-L....OH 	 OH 
H 	 H 
	
H 
Vitamin B6 	 Pyridoxal-5-phosphate 	PLP-amino acid 
Pyridoxine (PLP) 	 external aldimine 
[18] 	 (19] [20] 
Figure 1.20: Vitamin B6 PLP and PLP —amino acid external aldimine 
PLP has two basic roles in the reactions it mediates: through the aldehyde group it forms imine 
bonds with the amino groups of its substrates (20, Figure 1.20); and it acts as an electron sink, 
providing extensive charge delocalisation and stabilising the carbanion intermediates formed in 
catalysis. 
The types of enzyme utilising a PLP cofactor can be split into three main categories, according 
to the carbon centre at which the transformation occurs (see Figure 1.21). 
I 	02 
+ 
R 7 T a NH3 
X 
Figure 1.21: Generalised amino acid showing a-, -, 7-carbon centres 
a-carbon reactions: catalysing transamination, racemisation, or decarboxylation at the cx-
carbon. In this case the nature of the enzyme dictates the substituent that will undergo reaction. 





3-carbon reactions: catalysing elimination or replacement at the 0-carbon. These reactions 
typically involve elimination of X if it is a good leaving group, or replacement of X with a 
nulceophile V. 
y-carbon reactions: catalysing elimination or replacement at the y-carbon. As with 3-carbon 
reactions, these involve elimination of Y or its replacement by nulceophile Y' 
A cartoon showing the different types of PLP dependant reactions can be seen in Figure 1.22. 
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Figure 1.22: Cartoon representing origins of PLP reaction specificities (Q = quinonoid) 
1.4.2 The Mechanism of PLP catalysis 
PLP dependant enzymes are well studied and the catalytic action of these enzymes is therefore 
well documented 94 . PLP exists as a Schiff base, with the aldehyde group forming an imine bond 
with the c-amino group of a lysine residue on the enzyme, known as the internal aldimine. 
Binding of the substrate displaces the lysine residue and forms an external aldimine, where the 
PLP forms a Schiff base with the substrate. The general mechanism for a PLP mediated reaction 
was proposed by Metzler, Ikawa and Snell 95 who performed a series of non-enzymatic model 
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reactions using metal chelating PLP-amino acid Schiff bases. It was found that there is the same 
basic reaction sequence for all categories of PLP dependant enzyme: 
initial mime formation; 
chemical modification via a carbaniomc intermediate; 
hydrolysis of the product imine. 
Dunathan proposed an answer to the question of the specificity of a PLP mediated reaction. The 
Dunathan hypothesis 96  suggested that the C  bond perpendicular to the pyridine ring of PLP has 
the largest overlap of its HOMO with the LUMO of the extended it-system of the imine and the 
pyridinium ring, and is therefore broken most easily. The hypothesis was confirmed by x-ray 
crystallographic studies on aspartate aminotransferase 97,  tiyptophan synthase 98 and tyrosine 
phenol-lyase 99, which found the CaH  bond to be perpendicular to the pyridine ring. Similar 
studies on dialkyl glycine decarboxylase found the carboxylate group to be held perpendicular 
to the pyridine ring 100 . 
On displacement of a substituent from the C  of the external aldimine a quinonoid intermediate 
is formed (see Figure 1.22). This is generally an unstable intermediate as it is formed only 
transiently, however formation of this intermediate is the main catalytic role in the action of 
PLP dependant enzymes. The reactions following the formation of the quinonoid intermediate 
are complex, requiring the controlled migration of protons and leaving groups. It is thought that 
this is mediated by the active site residues of the individual enzymes, with the position of the 
acidic and basic residues at the active site dictating the substrate and reaction specificity of the 
enzyme 101 .  
It can be seen in Figure 1.22 that each intermediate qurnonoid can be transformed into a number 
of different products. This results in the enzyme having two major roles: accelerating the rate of 
the desired reaction; and preventing the occurrence of alternative reaction pathways. In doing 
this the enzyme can therefore utilise the versatile PLP cofactor effectively. 
1.4.3 Inhibition of PLP Dependant Enzymes 
PLP dependant enzymes are attractive targets for the design of enzyme activated irreversible 
inhibitors for two main reasons 102  PLP dependant enzymes are involved in the in the 
metabolism of many physiologically important compounds. Specific inhibitors of these enzymes 
could therefore be of therapeutic interest, as the metabolism of these compounds may result in a 
pathological condition. PLP dependant enzymes are ideal for the design of inhibitors as the 





mechanism of action is well understood, facilitating the selection of a suitable group for 
activation during catalysis. The covalent binding between substrate and PLP can be utilised, as 
any reactive intermediate generated cannot easily leave the active site, resulting in an 
advantageous situation for bond formation between the intermediate and enzyme. The nature of 
PLP as an electron sink, stabilising carbanionic intermediates can be used to generate an 
electrophillic intermediate that can react with suitable nucleophillic groups present in the side 
chain of the amino acid residues in the enzyme active site. 
The most general approach to the design of inhibitors for PLP dependant enzymes has been to 
incorporate suitable groups into the substrate to alter the fate of the quinonoid intermediate and 
generate an electrophillic imine to react with the residues in the active site. The structure of 
these iniines is normally closely related to that of the parent compound, with the most effective 
alterations being the addition of an alkene, alkyne or halogen functionality. 
1.5 Inhibition of Biotin Biosynthesis 
Biotin biosynthesis via the previously described pathway occurs only in plants and micro-
organisms, and as such is an ideal target for the development of inhibitors as non-toxic 
herbicides. It has been shown that actithiazic acid and aniclenomycin, compounds isolated from 
the culture filtrates of Streptomyces species, are inhibitors of biotin synthase 103 and DANS 104, 
and inhibit the growth of mycobacteria. Preliminary experiments on lavender cells (Lavendula 
vera) have shown that plant biotin synthase has also been inhibited by the anti-microbial 
actithiazic acid 45 , supporting the theory that inhibitors of microbial enzymes could also have 
herbicidal properties. 
1.5.1 Inhibition of PLP Dependant Enzymes used in Biotin Biosynthesis 
Enz-PLP + L-Alanine 
Pimeloyl C0A 




2 5cJ F 
Intermediate 
[21] 





Enz-13 1_13 + AON [8] 
Figure 1.23: Intermediate (18) used to design inhibitors of AONS 
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The AONS enzyme in the biotin biosynthetic pathway has been extensively studied, and there is 
much known about its mechanism of action (see section 1.3.2). This has lead to the design of 
substrate analogues and inhibition studies by the group of Marquet' 05 From their studies on the 
mechanism of the B.sphaericus AONS enzyme 54,106,107 the group designed six analogues based 
on the reaction intermediate (21, Figure 1.23) and transition state intermediate and tested them 
as inhibitors of AONS. The results of these tests can be seen in Table 1.1. 
Table 1 .1:Summary of inhibition data of compounds designed by Marquet and co-workers 105 
Compound Structure Inhibition Type K1 (pM) K1! Km L-Ala 
H2NC0 






H3C P03 H2 
OH 
23 H2N>L No inhibition - - 




No inhibition - - 
P03H2 
0 	OH 	 0 
25 
OOH Competitive/L-Ala 68 0.027 
H3C" CO2H 
OH 	 0 
26 Competitive/L-AIa 80 0.032 
H3C CO2H 
The first compound tested was D-alanine, which was found to be a competitive inhibitor of 
AONS. D-alanine is not a substrate for the enzyme as it does undergo C2-H proton exchange 
with the solvent, but binds more tightly to the active site than L-alanine. This occurs as the 
acylation step occurs with inversion of configuration, and D-alanine can mimic the reaction 
intermediate, binding tightly to the active site. 
In their design of the other inhibitors tested the Marquet group based their design on work by 
Bartlett and Giangiordano' °8  Their work found that the phosphonate group possessed the 
structural and electronic requirements to mimic the tetrahedral transition state generated from 





the hydrolysis of esters and related compounds. Marquet eta! also used an alcohol group as 
another tetrahedral transition state analogue. These functionalities provided mixed results, with 
compounds 22, 25, and 26 exhibiting competitive inhibition while compounds 23 and 24 
showed no inhibition. It was thought that the presence of three negative charges on 24 at pH 7.0 
may have prevented interaction with the active site, while it was rationalised that the 
diastereomers of 23 may adopt different conformations preventing interaction with the active 
site. 
1.5.2 Inhibition of Other Enzymes used in Biotin Biosynthesis 
As the most extensively studied enzyme in the biotin biosynthetic pathway DTBS was the target 
for inhibition by the group of Baxter  109. This group targeted the nucleoside base binding site of 
the DTBS protein with a view to inhibiting its action. 
The group of Sawyer used the detailed knowledge of the ATP binding site in DTBS 73'74'75"° to 
design a small molecule that would bind specifically to the purine binding elements in the active 
site. Three atoms of the adenine base form specific H-bonds to the DTBS protein: the 6-NH2 
forms H-bonds to the carbonyls of proline204 and asparagine 175; N-7 is H-bonded to the amine 
of asparagine 175, the optimal position for nucleotide binding is ensured by a second H-bond 
from the asparagine175 amine to valinel 13; the third H-bond is between N-i and the main 
chain nitrogen of leucine206. Hydrophobic interactions sandwich the adenine ring between 
proline206, valine 17 and the asparagine 1 75-threonine 178 loop. These features confer 
specificity for ATP on the binding site, with CT? and GTP acting only as poor substrates. It was 
found that the simplest molecule to fit these binding specificities was 6-hydroxypyrimidin-
4(3H)-one (6-HP4, 28, Figure 1.1). 
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Figure 1.1: ATP and adenine mimic 6-hydroxypynmidin-4(3H)-one 
Sawyer et al have shown that 6-HP4 is bound specifically in the adenine binding pocket of 
DTBS with many protein ligand interactions. 6-HP4 is H-bonded to the carbonyl and amine 
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groups of asparagine175, to the nitrogen of leucine206 and the carbonyl of alanine207; there are 
also similar hydrophobic interactions to those formed between the active site and adenine. The 
difference in binding arises around the carbonyl of proline204, with ATP as the substrate there 
is a H-bond present, however this does not occur when 6-HP4 is the substrate. 6-hp does 
however make a hydrophobic interaction with the side chain of isoleucine203. It was noted that 
6-HP4 could bind to the active site in a number of different orientations and tautomeric forms, 
however 28 (Figure 1.1) gives the optimum number of interactions with the active site. 
Kinetic measurements showed that 6-HP4 is a competitive inhibitor for DTBS, although it does 
have a relatively high K (11.2 ± 1.0 mM). It was expected that 6-HP4 would bind more weakly 
than ATP as 6-HP4 lacks the charged sugar-phosphate tail of ATP. Comparing the 6-HP4 
inhibition constant is to the ATP analogue AMP-PNP (K, ca 50p.M) it can be seen that this is 
103 times better, however the 6-HP4 inhibition constant is 5 times greater than that of adenine 
(K, = 2.2 ± 0.5 mM). 
1.6 Aim of This Study 
The biotin biosynthetic pathway is an ideal target for the development of pathway specific 
inhibitors that could act as non-toxic herbicides (see section 1.5). The main body of this work 
has been directed towards the identification and developments of synthetic routes to 
intermediates in the biotin biosynthetic pathway, with a view to the development of synthetic 
inhibitors of the enzymes involved in their formation. 
The first objective was to develop a synthetic route to 8-amino-7-oxononanoate (AON, 8), 
based on previous work in our laboratory 111 . The second objective was to identify and develop a 
new route towards the synthesis of AON, and extend this route to allow the synthesis of and 
array of AON analogues. The third objective was to test these analogues against the AONS and 
DANS enzymes, and identify any substrate activity with the DANS enzyme. 
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2.1 Dakin West Reaction 
The base catalysed formation of an a-acetylamino alkyl methyl ketone from an a-amino acid 
and acetic anhydride (Figure 2.1) was first reported by Dakin and West in 192 8'12,113,114.  Initial 
studies on the reaction of acetic anhydride and pyridine with several amino acids, 
R 	 00 	 0 	R 
NH2CO2H RAOA 
	




Amino Acid 	 cz-Acetyl amino alkyl methyl ketone 
Figure 2.1: Dakin-West reaction 
found that primary a-amino acids were converted into the corresponding a-amino ketones with 
the release of an equimolar amount of carbon dioxide. Further work has shown that the Dakin-
West reaction works equally well with secondary and non amino acids. Changing the basic 
catalyst from pyridine to an alkyl pyridine 115 a tertiary alkyl amine 115 or to sodium acetate 116 
has improved reaction yields, although increasing the steric bulk of the amine does reduce the 
reaction rate and yield. The scope of the reaction has been further extended to include larger 
acid anhydrides 117 but in general yields decrease with increasing anhydride chain length. 
2.1.1 Reaction Mechanism. 
NH2 
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L-amino acid 	 oxazolone 	 resonance 	 acylated 
intermediate stabllsed oxazolone 
carbanion (29) 	 (30) 
R 0 R 	
0 
RCO2H 	 H 	R 	OH 	
0 COR  
,R, N)<CO2R. 	RCO)2O 0 - co 	 - , JL..,_NHCOR. 
H 	 ROCHN 	 ROCHN2R 
R 0 
a-acyl amino alkyl 	 a-acylamino alkyl 	 a-acylamino alkyl 
methyl-fI-keto ester methyl-1-keto acid methyl ketone 
(31) 	 (32) 
Figure 2.2: Dakin West reaction mechanism 
A number of mechanisms were originally proposed for the Dakin-West reaction, but all met 
with objections. Dakin and West proposed the involvement of an oxazolone intermediate that 
gives rise to the same product as the parent amino acid" 3 . Kinetic studies 118  have shown that the 
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oxazolone reacts at the same apparent rate as the parent amino acid to form an a-acylamino 
ketone. The initial (fast) step in the reaction mechanism, Figure 2.2, is acylation and cyclisation 
of the amino acid to form the oxazolone (29). Reaction with the basic catalyst forms the 
resonance-stabilised carbanion, which is subsequently acylated by the acid anhydride to form 
30. This then undergoes ring opening and deprotection to from the a-acylamino-3-keto acid 
(31). The driving force for the reaction is the decarboxylation of 31, and the subsequent 
tautomerisation to form the a-acylamino ketone (32). 
2.1.2 Improvements on the Dakin-West Reaction 
Over time the Dakin-West reaction has been improved to give higher yields and a more efficient 
use of starting materials. Attenburrow, Elliot and Penny 116  found that reacting the sodium salt 
of an N-benzoyl amino acid with acetic anhydride at room temperature gave the corresponding 
acyl oxazolone, which formed the a-acylamino ketone in higher yields than previously 
encountered. Steglich and HOfle have made further improvements in developing a "stepwise" 
Dakin-West reaction, which are outlined in detail below. 
2.2 Stepwise Dakin West Reaction 
In the course of a detailed study on the mechanism of acylation of oxa.zol-5-ones Steglich and 
Höfle made two main improvements to the Dakin-West reaction 119120121122.  The first of these 
was replacement of the acid anhydride acylating agent with an acid chloride 119 . Previous 
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Figure 2.3: Stepwise Dakin-West reaction 
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studies 112,  had shown that the reaction of an oxazolone with an acid chloride was difficult to 
control and resulted in poor yields, while the corresponding acid fluoride could be used more 
easily 117 Steglich and HOfle found that employing a stepwise process exemplified in Figure 2.3, 
where the pre-formed oxazolone was treated with Et 3N and an acid chloride gave a more 
satisfactory result. The reaction proceeded at room temperature under kinetic control to form the 
0-acyloxy oxazole (34) in high yield. The second development made by Steglich and Hofle was 
to improve the yield and efficiency of the acyl migration step. By changing the catalyst used 
form pyridine to 4-N,N-dimethylamino pyridine (DMAP) 120  the reaction time was decreased, 
the conditions were milder and the yield improved. Acyl migration was initially carried out by 
heating the 0-acyloxy oxazole in pyridine at 95°C for several hours, then distilling the mixture 
to give the thermodynamically stable C-acyl oxazolone (35). However it was found that 
addition of 0.05 molar equivalents of DMAP resulted in isomensation at room temperature in 
0.5-lh. 
2.2.1 Changes in the Reaction Mechanism 
In their early work on the mechanism of the Dakin—West reaction Steglich and HOfle studied the 
reaction of an oxazolone with an acetic anhydride-pyridine mixture using NMR 12' They 
originally proposed (Figure 2.2) that the resonance stabilised carbarnon reacted directly with the 
acetic anhydride to form the C-acylated oxazolone, however the NMR study indicated the 
presence of a previously undiscovered reaction intermediate (37, Figure 2.4). It seems 
reasonable that the acid anhydride reacts with the pyridine to form 37 and that subsequent 
rearrangement allows formation of the C-acyl oxazolone. 
	
N 	R1 	
R1 I "NOR 	 R1 
R2-( 	
(R30)20 	
- R2-(L N . 	 R 02Co pyridine 
(37) 
Figure 2.4: Steglich and Höfle acylation intermediate 
The mechanism proposed by Steglich and Höfle for the transformation of 0-acyloxy oxa.zole to 
C-acyl oxazolone (Figure 2.5) involves the initial formation of an ion-pair intermediate (38) 122 
DMAP reacts with the 0-acyloxy oxazole, abstracting the acyl group from the oxygen and 
forming an ion pair. This then forms a similar intermediate to that of (37, Figure 2.4) with 
rearrangement and elimination of DMAP giving the required C-acyl oxazolone. 
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Figure 2.5: Mechanism of acyl group migration 
The Dakin-West reaction is a good starting point for the synthesis of cc-amino ketones and the 
work of Steglich and Höfle has improved the yield, conditions and versatility of the reaction. It 
was therefore decided to investigate the "stepwise" Dakin-West reaction as a possible method 
for the synthesis of 8-amino-7-oxo nonanoate (AON, 8). 
2.3 Stepwise Dakin West Reaction in Synthesis of AON 
2.3.1 Using 4-methyl-2-phenyl oxazolone 
MeO2C(CH2)5COCI (41), 	N 	
R DMAP, THF Ac20 	 Et3N, __ __  
60% 	
Phj( 1 	68% 74% 
o— % 
(40) 	 (42) 





Overall Yield 4% 
Figure 2.6: Synthesis of AON (8) starting from 4-methyl-2-phenyl oxazolone (40) 
Previous work in our laboratory used N-benzoyl alanine as the starting point for the synthesis of 
AON, as shown in Figure 2.6. It was therefore decided to repeat this synthesis and develop the 
work in an attempt to improve reaction yields. N-benzoyl alanine (39) was prepared from 
benzoyl chloride and alanine under standard Schotten Bauman conditions at 4°C 123•  Reaction of 
39 with acetic anhydride formed 2-methyl-4-phenyl oxazolone (40) via cycisation of the mixed 
anhydride (Figure 2.7). The melting point of 40 was found to be 36-38°C, corresponding to that 
of the to racemate (mp=37-39°C 124)  Racemisation is expected in this instance as the C-4 proton 
has a PKa of 8.4 125  allowing facile interconversion of enantiomers, enhanced by heating in an 
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Figure 2.7: Oxazol-5-one formation 
Acylation of 40 with methyl-6-chlorcarbonyl hexanoate (41) and Et 3N at room temperature for 
14h formed the kinetically favoured 0-acyloxy oxazole (42, Figure 2.6), which was found to 
decompose slowly with time. Conversion to the more thermodynamically stable C-acyl 
oxazolone (43) isomer occurred on treatment of 42 with DMAP in dry TI-IF for 14h. It was 
found that increasing reaction time gave greater formation of 43, but this was accompanied by 
the slow decomposition of 42, and the optimum reaction time was found to be 14-16h. 
On the basis of the earlier literature it was proposed that the most suitable strategy for the 
formation of AON (8) would be a one-pot sequence involving a ring opening and deprotection 
sequence. This was achieved in low yield by treatment of 43 with HC1 (6M) at 80°C for 24h. 
TLC analysis revealed a number of reaction products including monomethyl heptanedioate, N-
benzoyl alanine, and alanine in addition to AON. The products were separated and purified by 
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Figure 2.8: Acidic ring opening of C-acyl oxazolone 
R'= (CH2)5CO2Me 
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The 1,3-dicarbonyl centres present in the C-acyl oxazolone mean there are two possible 
protonation routes, as shown in Figure 2.8. Route A shows the expected ring opening sequence 
where initial protonation occurs at the carbonyl group on C-5. However the ring opened moiety 
can undergo further hydrolysis by one of two routes. If route (a) is followed decarboxylation 
and deprotection occur to form AON. If however route (b) is followed the side chain is cleaved 
to form N-benzoyl alanine and methyl heptanedioate. 
Route B shows a much less desirable protonation course, where initial attack occurs at the 
carbonyl group on C- 1', giving rise to a retro-Claisen reaction where methyl heptanedioate and 
4-methyl-2-phenyl-oxazol-5-ol are formed. Further hydrolysis of the oxazolol gives rise to N-
benzoyl alanine. 
In order to improve the yield of the final ring opening and deprotection of the C-acyl oxazolone 
it was decided to investigate the use of 2,4-dimethyl oxazolone and 2-methyl-4-trifluoromethyl 
oxazolone as starting materials for the synthesis of AON (8), and represents a new approach to 
the synthesis of AON. It was hoped that by choosing an oxazolone with an electron donating C-
2 substituent and one with an electron withdrawing C-2 substituent that the effect of ring 
substituent on the retro-Claisen reaction could be determined. It was speculated that altering the 
C-2 substituent on the oxazolone would change the stability of the ring opened oxazolone to 
allow a more facile deprotection strategy to be employed, and promote hydrolysis via Route A 
(Figure 2.8). 
2.3.2 Using 2,4-dimethyl oxazolone 
Figure 2.9 shows the formation of AON via the Dakin-West reaction using N-acetyl alanine as 
the starting material. 2,4-Dimethyl oxazolone (44) was formed from N-acetyl alanine using an 
activated ester method 126  Dicyclohexyl carbodiixnide was added to N-acetyl alanine in dry THF 
to form an activated ester, which underwent cycisation forming 44 and dicyclohexyl urea The 
DCU was precipitated with ether and filtered to give 44 as a waxy solid. Formation of the 0-
acyloxy oxazole (45) and the C-acyl oxazolone (46) were performed analogously to the 
formation of 42 and 43 (Figure 2.6). Ring opening and deprotection were carried out in a one 
pot sequence, heating in HC1 (4M) at 80°C for 4h and subsequent stirring at room temperature 
for 12h. The product mixture was separated and purified by ion exchange chromatography using 
DOWEX-50 (H from, eluting, with HC1 0-1M), to give a mixture of products, with AON in 
10% yield. 
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Figure 2.9: Synthesis of AON using 2,4-dimethyl oxazolone (44) and 
2-methyl-4-trifluoromethyl oxazolone (47) 
2.3.3 Using 2-methyl-4-trifluoromethyl oxazolone 
Figure 2.9 shows the synthesis of AON using alanine as the starting material. 2-Trifluoro-4-
methyl oxazolone (47) was formed from alanine and trifluoroacetic anhydride 127  at 140°C via 
cyclisation of the mixed anhydride. Reaction with methyl-6-chlorocarbonyl hexanoate (41) and 
Et3N formed the 0-acyloxy oxazole (48), which was isomerised to the C-acyl oxazolone (49) 
using DMAP. Ring opening and deprotection with HC1 (4M) at 80°C for 12h gave AON (8) in 
17%, in addition to the other products as seen previously. 
2.3.4 Comparison of the Three Methods for the Synthesis of AON 
It can be seen above that using benzoyl alanine as the starting material for the Dakin-West 
reaction affords 2-methyl-4-phenyl oxazolone (40) in 62% yields, with the acylation affording 
the 0-acyloxy oxazole (42) in 74% yield and isomerisation to the C-acyl oxazolone occurring in 
68% yield. Final ring opening and deprotection affords AON (8) in 14%, giving an overall yield 
of 4%. When N-acetyl alanine is used as the starting material 2,4-dimethyl oxazolone is formed 
in 58% yield. Subsequent acylation gives the 0-acyloxy oxazole (45) in 64% yield, with 
isomerisation giving the C-acyl oxazolone in 48% yield. In this instance ring opening and 
deprotection affords AON (8) in 10% yield, an overall yield of 2%. The oxazolone 2-methyl-4-
trifluormethyloxazolone (47) is formed in 95% yield from alanine and trifluoroacetic anhydride, 
with acylation giving the 0-acyloxy oxazole (48) in 68% yield. Subsequent isomerisation 
affords the C-acyl oxazolone (49) in 65% yield, with deprotection and ring opening giving AON 
(8) in 17%, an overall yield of 7%. A summary of these results is shown in Graph 2.1. 
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Graph 2.1: Comparison of the yields of the stepwise Dakin-West reaction using different oxazolones 
• 2-methyl-4-phenyl 
oxazolone 






The differences in yield observed in the formation of oxazolones 40, 44 and 47 can be attributed 
to due to an easier separation of 47 from its by products. In this instance distillation under 
reduced pressure afforded pure 47, whilst 40 and 44 required repeated crystallisation to afford a 
waxy solid. The yields of 0-acyloxy oxazoles (42, 45 and 48) are comparable for each of the 
oxazolone starting materials used. The yields experienced for the formation of the C-acyl 
oxazolones 43 and 49 are comparable, however the yield of the C-acyl oxazolone 46 is much 
lower. This can be rationalised by looking at the ion-pair intermediate (38, Figure 2.5) formed 
on treatment of the parent 0-acyloxy oxazole with DMAP. The intermediate 38 has a 
delocalised negative charge which can be readily stabilised by both the phenyl and 
trifluormethyl substituents, however, this does not occur with the methyl substituent, thus 
lowering the yield of this reaction step. Low yields are experienced when all three C-acyl 
oxazolones undergo ring opening and deprotection, however Graph 2.1 shows that the 49 gives 
the highest yield of AON (8), due to a more facile hydrolysis as a result of the electron 
withdrawing effect of the CF 3 substituent. In the case of 46 the inductive effect of the methyl 
group causes a more difficult hydrolysis thus reducing the reaction yield. 
As this strategy had not been as successful as anticipated, a different approach to the final ring 
opening and deprotection step was adopted. It was decided to investigate an enzymatic ring 
opening of the C-acyl oxazolone followed by a separate deprotection step to give the final 
product. 
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24 An Enzymatic Approach to the Synthesis of AON 
By using an enzymatic ring opening method it was hoped that the problem faced by competing hydrolysis 
routes ( 
Figure 2.8) would be avoided. The advantage of taking an enzymatic approach would be 
production of AON as its biologically active enantiomer (FS AON) where as the stepwise 
Dakin-West reaction produced AON as a mixture of enantiomers. To this end it was decided to 
investigate the use of the enzyme Lipozyme ®, which could be employed in the enantioselective 
oxazolone ring opening. 
2.4.1 The Use of Enzymes in Organic Chemistry 
In the last twenty years extensive studies 128,129,130 on the use of enzymes in synthetic organic 
chemistry have shown that there is a large degree of practical application for enzymes in 
chemical synthesis. Despite this knowledge chemists have been slow to employ enzymes in the 
course of their day to day reactions. There are many reasons for this lack of enthusiasm with the 
most important reason being the perceived necessity to work in aqueous solution. Research has 
now shown that this need not be the case, as many enzymes can function in organic solvents 
with little or no added water. This realisation has opened up the use of enzymes in synthetic 
chemistry as one no longer needs to worry about the insolubility of organic compounds in 
water, the promotion of side reactions by water, or unfavourable thermodynamic equilibria 
leading to low yields. 
2.4.2 Lipase Catalysed Oxazolone Ring Opening 
H 	 H 	0 
R C" 
CO2R NffO ROH Lipase 	
+ 	R COPh 
Ph 	 Ph 
(RS) 	 (R) 	 (S) 
f Partial in situ racemisation 	I 
Figure 2.10: Enantioselective enzymatic ring opening of oxazolones 
In the early nineties there was much research carried out on the enantioselective synthesis of L-
a-amino acids from oxazol-5-ones ' 3132" 33" 34"35 . This work focused on the enantioselective 
methanolysis, or butanolysis, of 4-substituted-2-phenyl oxazolones (Figure 2.10) using alipase, 
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such as porcine pancreatic lipase (PPL) or Candida cylinracea (CCL) 131  in an organic solvent. 
It had been found that enol esters underwent transesterification much faster than simple alkyl 
esters 136;  it was therefore proposed that oxazolones, as cyclic aza enol esters, should behave in 
the same way, as the reactions had similar mechanisms. Solvent studies showed that the reaction 
medium had an effect on the optical purity of the amino acid, and that changing the solvent used 
could improve the enantioselectivity of the lipase 132 It was suggested that it was possible to 
prepare any ct-amino acid in high optical purity and in the desired stereochemical form via the 
lipase ring opening of the oxazolone derivative. 









Figure 2.11: Racemisation and enzymatic ring opening of oxazolones 
An important finding of these studies was that the rate of raceniisation (k mc) of the two isomers 
of the oxazolone must be faster than the rate of enzyme catalysed ring opening (k). This in 
turn must be faster than the rate of non-enzymatic ring opening (k ehem). It was therefore 
important to find conditions which to promote k.,, and k enz whilst reducing kchem t33 ' 134 
When the lipase Lipozyme® (Mucor miehei) was used in solvent studies by Bevinakatti in 1992 
132 it was found that the S-isomer of the protected amino acid was formed. These studies showed 
dichioromethane to have the greatest enantioselectivity (69% ee), while diisopropyl ether 
(DIPE) the solvent used in previous studies showed the least selectivity (33% ee). Further 
studies by Turner in 1995 135  showed that using Lipozyme ® in toluene with 2 equivalents of n-
butanol and 0.25 equivalents of Et 3N added gave the required product in 69% yield, and 73% 
ee. Turner et al found that Lipozyme®  degraded slowly over time to form an isozyme which 
competed with the action of Lipozyme®. The addition of Et3N reduced the activity of this 
isozyme leading to overall higher yields. 
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2.4.3 The Use of Lipozyme® in the Synthesis of AON 
The method of Turner el a! 135 was employed for the ring opening of the C-acyl oxazolones and 
the synthesis of AON. The C-acyl oxazolones were treated with Lipozyme ® in a solution of 
toluene containing n-butanol (2 equivalents) and Et 3N (0.25 equivalents). The reaction mixture 
was shaken on an orbital shaker for 72h and purified by preparative layer chromatograph (plc). 
Analysis of the purified products revealed the major product to be dibutyl heptanedioate, with the other 
bands present containing the monoester. This could be the result of an acid type catalysis occurring in the 
enzymatic reaction. Acid catalysis would cause the same protonation pathway as seen in 
Figure 2.8, where there is competing hydrolysis at both the carbonyl at C-S and C- I'. Work by 
the group of Sih in 1993 133  found that the reaction rate and enantioselectivity depended greatly 
on the nature of the C-4 substituent. Previous studies on the enzymatic ring opening of 
oxazolones has focused on small alkyl groups as substituents at the C4 position, with Sih 
finding that the reaction rate decreased markedly for bulky C4 substituted oxazolones. In the 
case of 43, 46 and 49 the C-4 substituent is a bulky acyl group, which may not be recognised by 
the enzyme active site, or may not fit into the enzyme active site. This, in addition to the 
carbonyl group on the side chain probably account for the formation of dibutyl heptanedioate 
over AON. 
2.5 Conclusions 
Having investigated the use of three different oxazolones in the stepwise Dakin-West synthesis 
of AON it was found that using 4-methyl-2-phenyl oxazolone as the starting material gave AON 
in 4% overall yield, whilst 4-methyl-2-trifiuoromethyl oxazolone gave AON in 7% overall yield 
and 2,4-dimethyl- oxazolone gave AON in 2% overall yield. The low yield can be attributed to 
competing hydrolysis routes caused by the presence of a 1,3-dicarbonyl centre, whereby the C-
acyl oxazolone can be protonated on either the ring or the side chain carbonyl, resulting in a 
variety of products. To try to overcome this problem an enzymatic approach was taken to the 
oxazolone ring opening. This resulted in the formation of dibutyl heptanedioate, and could be 
the result of the bulky acyl side chain blocking the active site of the enzyme. 
To overcome these problems several different approaches could be adopted. It has been reported 
in the literature that the use of acetic anhydride and pyridine, or anhydrous oxalic acid can 
prevent the competing hydrolysis. In this instance the most suitable method to employ would be 
oxalic acid, as amino ketones form stable pyra.zine salts in basic conditions. A second approach 
trialed in the course of this work was to reduce the side chain carbonyl group to the alcohol with 
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sodium cyanoborohydride, achieving the alcohol in 85% yield. It was thought that the alcohol 
would be less susceptible to side reactions during hydrolysis and the resulting amino alcohol 
could be easily oxidised to the amino ketone. Due to time constraints this approach was not 
taken any further and other route for the synthesis of AON (8) and related compounds were 
investigated 
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3.1 Nitroaldol Reaction in the Synthesis of AON (8) 
The nitroaldol reaction provides a versatile approach to a range of nitroalcohols, as the 
aldehyde and nitroalkane starting materials can be varied depending on the mtroalcohol 
required. This intermediate can be reduced to form an aminoalcohol, or oxidised to give a 
nitroketone, which can subsequently be reduced to an aminoketone. It was therefore decided 
to adopt this approach for the synthesis of 8-amino-7-oxononanoate (AON, 8). 
On completion of the synthesis of AON it was anticipated that the compounds would be 
assayed with the 8-amino-7-oxononanoate (AONS) and 7,8-diaminononanoate (DANS) 
enzymes. It was hoped that assaying with both AONS and DANS would show product and 
substrate binding respectively and allow an in depth study on the binding of AON in the 
substrate binding site of DANS. To create a successful probe for this enzyme it was decided 
to synthesise a series of compounds related to AON. These compounds were designed to be 
varying in chain length and either contain a methyl group between the ketone and amino 
groups, or contain only a methylene group between the two functional groups. It was also 
decided to test the DANS and AONS enzymes with the aminoalcohols of identical structure. 
3.1.1 Henry (Nitroaldol) Reaction 
NO2 	 0 	
NO2 
R)-f- 1 " 
(50] 
Figure 3.1: Nitroaldol (Henry) Reaction 
The mtroaldol or Henry reaction ' 37"38 is a classical chain-lengthening reaction using a 
mtroalkane and a carbonyl compound to form a mtroalcohol (50, Figure 3.1). The versatility 
of the nitroaldol intermediate (50) makes this reaction a suitable starting point for a number 
of different transformations, such as mtroketone, aminoalcohol and mtroalkene formation 
(see Figure 3.2) 1 " 0 . 
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Figure 3.2: Transformations possible with nitroalcohol intermediate 
The Henry reaction is an aldol type reaction and as such relies upon a basic catalyst for 
generation of the stabilised carbanion intermediate (51, Figure 3.3). Stabilisation of the 
negative charge results in the formation of the ambident nulceophile (51a, Sib), related to 
both the nitroalkane and the nitronic acid (aci-nitro species, 52) through nitro-aci nitro 
tautomerism. It might be expected that carbanion 51 would form an 0-alkylated product due 
to the more electronegative nature of the oxygen end of the molecule, however this is not the 
case as the sole reaction product is the C-alkylated mtroalcohol 50. 
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Figure 3.3: Equilibria involved in formation of nitroalcohol (50) 
The nitroaldol reaction has been traditionally used to perform syntheses involving simple 
functional group interconversions (see Figure 3.2) and its progression to utilisation as an 
efficient and reliable enantioselective transformation has been aided by the availability of 
new chiral catalysts. These compounds have been used in the synthesis of adrenalin related 
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mediators of the sympathetic nervous system 141,142,143;  the carbohydrate components of 
anthracycline antibiotics 1;  HIV protease inhibitors 145,  and azole antifungal agents 147 
3.1.2 General Catalysts 
The success of the nitroaldol reaction depends on the choice of reaction conditions and 
catalyst employed. The choice of these is dependant on several factors such as the functional 
groups present; the solubility of the reactants and the ease of generation of the nitronate salt. 
Early studies on the mtroaldol reaction used strongly basic conditions, using alkoxides and 
hydroxides in alcohol or aqueous media as catalysts. More recently organic bases such as 
1, 1,3,3-tetramethylguanidine (TMG) in ether and THF; and amines such triethylamine and 
diisopropylamine in alcohol have been used as catalysts. Current work has concentrated on 
the development of new catalysts to reduce side reactions (e.g. dehydration of the 
nitroalcohol); to prevent the formation of normal aldol by-products; to avoid epimerisation 
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Figure 3.4: Proazaphosphatrane catalysts developed by Kisanga and Verkade 
To reduce self-condensation reactions where ketones are used as the carbonyl substrate 
Kisanga and Verkade have developed a series of proazaphosphatranes catalysts' 48 (53-55, 
see Figure 3.4). The undesirable self-condensation is reduced as the proazaphosphatranes 
exist as the protonated complex 56, forming a complex with the desired mtroalkane. To 
optimise the reaction conditions Kisanga and Verkade included magnesium sulfate in the 
reagent mixture to act as a Lewis acid and activate the carbonyl group. 
Recent work has focussed on the development of solvent-free and aqueous phase reactions. 
Ballini has established conditions for both of these types of reactions using the phase transfer 
catalyst cetyltrimethylammonium chloride to promote the reaction in aqueous conditions 149 
and A.mberlyst A-21 150  as the catalyst for the solvent free reaction of a series of aldehydes 
with 4-nitro-2-butanol. Other solvent free reactions have used microwave irradiation with 
ammonium acetate ' 5 ' or powdered KOH' 52 as the chemical catalysts for the reaction. 





3.1.3 Asymmetric catalysts 
The driving force for the development of asymmetric catalysts for the nitroaldol reaction has 
been the requirement for new routes to chiral aminoalcohols. These can be readily formed by 
the reduction of the nitroalcohol from the mtroaldol reaction, and various syntheses of 
complex natural products have been based on this strategy (see section 3.1). 
R Q OH 
OH vc& 
R = H, R-Binol 




Figure 3.5: Chiral catalysts used in asymmetric nitroaldol reactions 
Shibasaki has developed Bmol catalysts (57, 58, Figure 3.5) that have been used in the 
synthesis of several compounds of pharmaceutical interest. In their synthesis of the 13-
adrenoreceptor antagonist propanolol the Shibasaki group successfully used a lanthanum-
(R)-binaphthol complex derived from 57 to catalyse the formation of 60 141  Their procedure 
was further modified in their synthesis of the 13-adrenergic agent R-(-)-arbutamine, where the 
binol derivative 58 was used to form the intermediate 61. Corey has used the chiral 
quaternary salt 59 (Figure 3.5) to catalyse the formation of the nitroaldol intermediate (62) 
required for the synthesis of the HIV protease inhibitor Amprenavir ' 46 Menzel et al found 
that the catalyst giving the most favourable ratio of the desired L-arabino isomer of the 
nitroaldol 63: an intermediate in the synthesis of L-acosamine, the carbohydrate unit of 
anthracycline antibiotics; was a mixture of tetra-N-butyl ammonium fluoride (TBAF) and 
methyl-tert-butyl ether (MTBE). A summary of conditions employed for the use of these 
catalysts is shown in Table 3.1. 
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Table 3.1: Examples of asymmetric nitroaldol catalysts 
Nitroaldol 	
Target 	Catalyst Mix Yield e.e. Diastereo- Ref. 
Compound (%) 	(%) selectivity 







80 	92 	 141 
— — 
60 	 H20/THF 
OH 
HO NO2 	 53, 
R-(-)-Arbutamine 	Sm(O'Pr)3, 	93 	92 	 142 











L-A cosamine 	TBAF MTBE 95 	 nbol 	144 
OR NO2 OCH3 arabino/ 
63 	 xylo/ lyxo 
3.1.4 The Synthesis of AON (8) 
The nitroaldol reaction requires an aldehyde and a nitroalkane as its starting material. The 
desired nitroalkanes: nitroethane and nitromethane are readily available form a variety of 
commercial sources, however the desired aldehydes were not commercially available. To 
this end a series of aldehydes were synthesised and reacted with mtroethane and 
nitromethane to form the desired mtroalcohols. These were subsequently oxidised to from 
mtroketones and the nitro group reduced to the aminoketone, or the nitro group of the 
nitroalcohol reduced to form the desired aminoalcohol. 









reduction of acid chloride 
Ethyl-7-oxoheptanoate (64] 
Rosenmund reduction," 




Figure 3.6: Methods employed for the synthesis of ethyl 7-oxoheptanoate (64) 
The aldehyde ethyl 7-oxoheptanoate (64) is pivotal for the formation of AON via the 
nitroaldol reaction. As such its synthesis was carefully investigated and five approaches 
evaluated: Baeyer-Villiger oxidation of cycloheptanone; Rosenmund reduction of ethyl-6-
chiorocarbonyihexanoate; aluminium hydride reduction of ethyl-6-chlorocarbonylhexanoate, 
using sodium tri-t-butoxyaluminohydride; and tin hydride reduction of ethyl-6-
chiorocarbonyihexanoate. These are outlined in Figure 3.6, and discussed in detail below. 
3.2.1 Baeyer-Villiger Oxidation of Cycloketones 
EN 






Figure IT Reaction Mechanism for Baeyer-Villiger oxidation of ketones 
The Baeyer-Villiger reaction is the oxidation of ketones with peroxy acids to form esters or 
lactones The two-step mechanism (see Figure 3.7) proceeds via initial addition of the 
peroxy acid to the carbonyl of the ketone, forming the intermediate 65. The second step is 





usually rate determining and involves the migration of the R' group from carbon to oxygen 
and the breaking of the oxygen-oxygen bond in a concerted process. 
0 





(66] 	 (64] 
Figure 3.8: Baeyer-Villiger oxidation of cycloheptanone to form ethyl 7-oxoheptanoate (64) 
The Baeyer-Villiger reaction has wide ranging use 153,  and was adopted for the synthesis of 
ethyl 7-hydroxyheptanoate (66) by Robinson and Smith 154  as early as 1937, and later used 
for the synthesis of ethyl 7-oxoheptanoate (64) by BalIini' 55 in 1991(see Figure 3.8). 
Oxidation of cycloheptanone with potassium persulfate in ethanol and sulfuric acid affords a 
lactone intermediate, which undergoes ring opening to give ethyl 7-hydroxyheptanoate (66). 
It could be conjectured that the alcohol can then be oxidised using PCC or PDC in DCM to 
give ethyl 7-oxoheptanoate (64). In their work Robinson and Smith also reported the 
synthesis of ethyl-6-hydroxyhextanoate and ethyl-5-hydroxypentanoate in acceptable yields. 
3.2.1.1 Baeyer-Villiger synthesis of ethyl 7-hydroxyheptanoate (66) and related 
compounds 
The successful use of the Baeyer-Villiger reaction in the synthesis of aldehydes by Baum et 
a! and Robinson and Smith gave an indication that this might be a useful route to the 
aldehydes required. It was therefore decided to adopt this method for the synthesis of a range 
of aldehydes to be used in the mtroaldol reaction. 
The oxidation of four cycloketones: cycloheptanone, cyclooctanone, cyclohexanone and 
cyclopentanone was investigated. Typically the cycloketone in ethanol were added drop-wise 
to a solution of potassium persulfate, sulfuric acid, water and ethanol at 15°C, following the 
procedure of Ballini' 55 Ballim et al suggest purification by distillation, however in our 
hands it was found that distillation was unsuccessful, but that purification of the products 
could be achieved by silica gel chromatography. The yields of ethyl 7-hydroxyheptanoate 
(66), ethyl 8-hydroxyoctanoate (67), ethyl 6-hydroxyhexanoate (68) and ethyl 5-
hydroxypentanoate (69) obtained are shown in Table 3.2. 






Table 3.2: 	Yields of the Baeyer-Villiger synthesis of 66 and related compounds 155  








37 	 Cyclooctanorie 
0 
68 	 33 	 Cyclohexanone 
EtO 
0 
69 	 28 	 Cyclopentanone 
EtO 
In their original study on the formation of 66 from cycloheptanone Robinson and Smith 
found that the yields obtained are sensitive to reaction conditions, especially temperature 154.  
The reactions were therefore repeated taking care to ensure a maximum temperature of 15°C 
throughout, however this did not greatly improve the yields. In their original study Robinson 
and Smith achieved a maximum yield of Ca. 50%, although this was improved by Ballini et 
al who reported yields of 85%. A possible explanation for the low reaction yield in our hands 
could be the production of a side product giving off a strong odour of pineapple which has 
been isolated in the past 154 Robinson and Smith suggested that this compound was a 
dilactone with a 16-membered ring, related to 7-hydroxheptoic acid; based on the work of 
Natta ci a!' 56 on large dilactones and Ruzicka ci a!' 57 on the relation between odour and 
large ring dilactones. Despite the attraction of characterising this elusive compound I 
avoided the temptation to pursue this further. 
3.2.1.2 Synthesis of ethyl 7-oxoheptanoate (64) and related compounds 
After numerous trials ethyl 7-oxoheptanoate (64), ethyl 8-oxooctanoate (70), ethyl 6-
oxohexanoate (71) and ethyl 5-oxopentanoate (72) were synthesised by oxidation of their 
respective hydroxy esters. The best procedure proved to involve adding a solution of 
hydroxy ester in DCM drop-wise to a stirring solution of pyridinium dichromate (PDC) in 
DCM, cooled to 5°C. The products were routinely purified by silica gel chromatography. 
While this approach appeared to be straightforward, considerably difficulty was encountered 





Table 3.3: Oxidation of hydroxy esters to form Ethyl 7-oxoheptanoate (64) and related compounds. 
Compound 	 Structure 	 Yield 	
Overall 	Starting
Yield (%) Material 
64 
	
51 	 11 	 66 
0 
70 	 41 	 15 	 67 
0 
0 
71 	 46 	15 	 68 
0 
0 	 0 
72 	
EtO" "11'H 	
42 	12 	 69 
in achieving satisfactory yields, as shown in Table 3.3. 'H NMR the confirmed the structures 
of compounds 64, 70, 71 & 72. Each 'H nmr spectrum exhibited an: ethyl ester methyl triplet 
and methylene quartet at 1.2ppm and 4.lppm; -CH 2CHO methylene triplet at 2.2-2.5ppm; 
and the aldehyde proton (-CO) singlet at 9.8ppm. 
In an effort to improve this procedure PDC was substituted by pyridinium chlorochromate 
(PCC), however this was unsuccessful. Incomplete oxidation of starting material was 
responsible for the low yields of 64, 70, 71 and 72, and efforts to increase the yields by 
increasing reaction temperature proved futile, resulting in the formation of the corresponding 
acids. 
In light of the low yield experienced from the Baeyer-Villiger oxidation to form the hydroxy 
ester starting material it was decided not to optimise this reaction, and methods of aldehyde 
formation form acid chlorides' 58 were investigated. 





3.2.2 Rosenmund Reduction of Acid Chlorides 
0 	 0 
)L CI 	
1. Oxalyl chloride AH 
2. H2 , Pd-C, ('Pr) 2EtN 
Figure 3.9: Rosenmund reduction of acid chlorides to form aldehydes 
The Rosenmund reaction, first described in 1918 159,  is one of the most direct methods for the 
conversion of acid chlorides to aldehydes. Typically the Rosenmund reaction is carried out 
by bubbling hydrogen through a hot suspension of the acid chloride and supported palladium 
catalyst. A major limitation of this procedure is over-reduction of the acid chloride, forming 
the corresponding alcohol. This can be avoided by the addition of a suitable catalyst poison, 
to inactivate the Catalyst 160. Temperature plays an important role in the Rosemnund reaction, 
with optimal yields achieved if the temperature is kept near the lowest temperature required 
for hydrogen chloride evolution 160 
The Rosenmund reaction was developed by Sakurai and Tanabe 161  who found that the 
reaction could be carried out at room temperature using acetone as a solvent if N,N-
dimethylaniline was used as a hydrogen chloride acceptor. It was later found that N,N-
dimethylaniline was itself reduced under the reaction conditions and Peters and van Bekkum 
refined the process using ethyldiisopropylamine as the hydrogen chloride acceptor 162 
3.2.2.1 Rosenmund Reduction of Ethyl 6-chlorocarbonylhexanoate (74) 




- _--.-  O Chloride 	 r' 
	
(P)2EIN 	Et 
[73] 	 (74] 	 (65] 
Figure 3.10: Formation of ethyl 7-oxoheptanoate (64) from ethyl heptanedioate (73) 
As a test case, to evaluate the Rosenmund procedure ethyl 7-oxoheptanoate (64) was 
synthesised from ethyl 6-chlorocarbonylhexanoate (74). Ethyl 6-chiorocarbonythexanoate 
(74) was prepared in 93% yield from ethyl heptanedioate (73) and oxalyl chloride. Freshly 
distilled 74 was added to a pre-hydrogenated suspension of palladium on charcoal in acetone 
and diisopropylethylamine, and stirred in a hydrogen atmosphere for lh according to the 
procedure of Peters and van Bekkum 162 Aqueous work up and distillation of the product 
(lipo .02 = 79°C) afforded ethyl 7-oxoheptanoate (64) in a disappointing 26% yield. Repetition 
of this procedure gave erratic results, with yields varying greatly, but never greater than 
26%. It has been noted by others that over reduction is a common problem with the 





Rosenmund reaction 160  however this problem was found to be minimal (always less than 
1%) using the method of Peters and van Bekkum' 63 A possible explanation for the low 
yields experienced here could be product polymerisation during distillation, resulting in 
some of the dark residues recovered. 
3.2.3 Sodium tri-t-butoxyaluminohydride reduction of Ethyl 6-
chlorocarbonyihexanoate (74) 
In the course of a study on the reducing characteristics of sodium aluminium hydride 
derivatives Brown and Cha 164 found that sodium tri-t-butoxyaluminohydride (STBA) gave 
facile and efficient reduction of acid chlorides to aldehydes as shown in Figure 3.11. 
0 	 0 	 0 	 0 
EO) LCI STBA 
	
EtO H 
[74] 	 [64] 
Figure 3.11: STBA reduction of ethyl-6-chlorocarbonylhexanoate (74) to form (64) 
In the initial trails STBA was prepared by reacting sodium aluminium hydride in diglyme 
with 3 equivalents of t-butanol at 0°C for 6h. The reagent was then used to effect the 
reduction of ethyl-6-chlorocarbonylhexanoate (74) to ethyl 7-oxoheptanoate (64). The 
procedure involved drop-wise addition of STBA in diglyme to a cooled (-78°C) solution of 
74 in thy THF. Purification by silica gel chromatography and tic analysis of the crude 
reaction mixture from this procedure revealed the sole product to be ethyl 7-oxoheptanoate 
(64), however purified yields of 64 were never more than 27%. This was due to difficulties 
in separating the product form the diglyme. Several approaches to this problem were 
attempted: repeated extraction with water did remove the diglyme, but also caused some 
decomposition of 64; purification by silica gel chromatography was partially successful; and 
distillation proved unsuccessful resulting only in a reduced volume of diglyme present with 
the product. Although this concept was successful in concept, showing the only aldehyde 
present by tic (DNP staining), the difficulty in removal of the solvent without adversely 
affecting the yield of aldehyde proved impossible to overcome and other more practical 
approaches had to be studied. 
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3.2.4 Organotin Hydride Reduction of Acid Chlorides 
RCOCI 	
R3SnH 	
RCHO + RCH 2CO2 R 
Figure 3.12: Reduction of acid chlorides to aldehydes and esters 
The next logical step for the synthesis of ethyl 7-oxoheptanoate (64) was to employ tin 
hydride chemistry. Organotin hydrides have been known to reduce acid chlorides since the 
early1970s 165,  however the original reaction conditions were not suitable for the formation 
of aldehydes due to the competing formation of esters (see Figure 3.12). The reaction was 
modified in the early 1980s by the addition of a tetrakis(triphenylphosphine)palladium 
catalyst, and this was found to be completely selective towards the formation of aldehydes 
166 Detailed studies on this modified procedure found that it could be applied to a wide range 
of acid chlorides - both aliphatic and aromatic, and that the reaction tolerated the presence of 
a wide range of reducible functionalities 167 
3.2.4.1 Mechanism of Action 
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Bu3SnCI 	 Bu3SnCI 
Figure 3.13: Mechanism for the Bu3SnH I (PPh3)4Pd reduction of acid chlorides 167 
It was originally thought that the tin hydride mediated reduction of acid chlorides had a free 
radical 	ani 165 In the case of the palladium mediated reduction this route has been 
eliminated and Four and Guibe have proposed two plausible mechanisms both of which 
involve the acyihydridopalladium (II) complex (75, Figure 3.13). The first pathway (AB, 
Figure 3.13) involves the oxidative addition of the acid chloride to (PPh 3)4Pd, forming the 
acylcbloropalladium (II) complex (76), this is followed by a metathesis reaction between 76 
and Bu3Sn}{ givingBu3SnCl and 75. The first step in the second pathway (CD, Figure 3.13) 





is the oxidative addition of Bu 3SnH to (PPh3)4Pd giving 77, a subsequent metathesis reaction 
of this with the acid chloride gives rise to 75. In both pathways the aldehyde is formed by 
reductive elimination from 75. 
3.2.4.2 Synthesis of Ethyl 7-oxoheptanoate (64) and related compounds 
0 	 0 	 0 	 0 
EO) LCI 	
Bu3SnH, 	
EO (H (PPh3 )3Pd 
1741 	 [64] 
Figure 3.14: Tin hydride reduction of ethyl-6-chlorocarbonylhexanoate (79) to form (64) 
Ethyl 7-oxoheptanoate (64) was prepared from ethyl 6-chiorocarbonyihexanoate (74) using 
the procedure of Four and Guibe' 67 (see Figure 3.14). Other aldehydes were prepared from 
their corresponding acid chlorides. Ethyl 6-chiorocarbonylhexanoate (74); methyl 5-
chlorocarbonylpentanoate (78); and ethyl 7-chlorocarbonylheptanoate (79) were routinely 
prepared in good yield by heating the parent acid at reflux with oxalyl chloride in DCM. The 
acid chlorides were purified by Kugelrohr distillation (for yields see Table 3.4) and the 
structures were confirmed by 1 11 NMR evidence. The ethyl ester groups of 74 and 79 gave a 
triplet at 1.2ppm (CH3CH2) and a quartet at 4.lppm (-CH 2); the methyl ester group of 75 
gave a singlet at 3.7ppm; the CH 2COC1 methylene protons gave a triplet at 2.9ppm. It was 
found that all the acid chlorides could be stored at -20°C for up to 4 weeks without 
significant decomposition. 
Table 3.4: Yields of formation of ethyl 6-chlorocarbonylhexanoate (74), and related acid chlorides 
(78 & 79). 
Compound 	 Structure 	 Yield (%) 	bp (°C, mmHg) 
0 	 0 
74 	 93 	 90 (0.04) 
EtO 
0 




91 	 100 (0.02) 





Ethyl 7-oxoheptanoate (64) was prepared by adding Bu 3SnH (1.1 equivalents) to a 
suspension of ethyl 6-chlorocarbonylhexanoate (74) and (PPh 3)4Pd (0.01 equivalents) under 
N2 . The reaction proceeded rapidly and was found to be complete within lh. The catalyst 
was removed by initial evaporation of the bulk of the solvent followed by precipitation with 
hexane and filtration. The aldehyde was purified by Kugelrohr distillation (bp o .02 = 79°C) and 
could be stored at -20°C for up to 2 weeks. 
Ethyl 4-oxobutanoate (80); methyl 6-oxohexanoate (81); and ethyl 8-oxooctanoate (70) were 
prepared in a similar manner starting from ethyl succinyl chloride, methyl 5-chlorocarbonyl 
pentanoate (78); and ethyl 7-chlorocarbonylheptanoate (79) respectively. The yields and 
boiling points of these compounds are shown in Table 3.5. It was found that distillation 
afforded pure aldehydes, and NMR characterisation showed the presence of the aldehyde 
proton (-CHO) at 9.8ppm (singlet), and the (-CH 2CHO) methylene protons at 2.4ppm 
(triplet). The presence of the ethyl ester groups was shown by signals at Ca. i . 2ppm (triplet) 
and Ca. 4. lppm (quartet) corresponding to the methyl and methylene protons, and the methyl 
ester group was shown by a signal at 3.7ppm (singlet). No tributyltin chloride residues were 
present in the purified compounds. 
Table 3.5: Yields of formation of the ethyl 7-oxoheptanoate (64) and related aldehydes (80, 81 & 70) 
Compound Structure 	 Yield (%) Overall Yield (%)* bp (°C, mmHg) 
o 	 o 
64 74 69 79 (0.02) 
0 
80 EtO _ j(H 	80 80# 60 (0.02) 
0 
0 
81 MeO J /1f H 	83 80 65 (0.02) 
0 
0 
70 87 79 95 (0.02) 
0 
* From starting acid, # from ethyl succinyl chloride 





3.3 Nitroalcohol Synthesis 
The nitroaldol reaction can be catalysed by a number of different reagents as shown in 
sections 3.1.2 and 3.1.3, (pp.45). Trial reactions using aldehyde and mtioalkane supported on 
silica 168  or alumina 169,170  yielded nitroalcohol, however on scale up it was found that 
incomplete use of starting materials and dehydration of the product gave low yields of 
nitroalcohol. This coupled with problems experienced isolating the product from the solid 
support meant that other methods for the synthesis of nitroalcohols were investigated 
3.3.1 Synthesis of ethyl 7-hydroxy-8-nitrononanoate (82) and related 
compounds 









Figure 3.15: Nitroaldol reaction of ethyl 7-oxoheptanoate (64) and nitroethane to form ethyl 7-hydroxy-
8-nitrononanoate (82) 
Wollenberg and Miller studied the mtroaldol reaction as a method of synthesising 
nitroalkanes in 1978 171  . Their work found that bases previously reported as catalysts failed 
to initiate any reaction between octanal and nitromethane. They found however, that 
potassium fluoride and potassium hydroxide in iso-propanol could be used successfully to 
synthesise nitroalcohols, which were subsequently acylated and reduced to give the desired 
nitroalkane. It was therefore decided to use powdered KOH in iso-propanol as the catalyst 
for the synthesis of aliphatic nitroalcohols as intermediates in the synthesis of a series of 
aminoketones including 8-amino-7-oxononanoate (8). 
Ethyl 7-hydroxy-8-mtrononanoate (82, Figure 3.15) was synthesised using the method of 
Wollenberg and Miller: ethyl 7-oxoheptanoate (64) was added solution of nitroethane and 
powdered KOH (0.05 equivalents) in iso-propanol, and the reaction mixture stirred for 6h. 
Precipitation of the catalyst and filtration of the suspension gave ethyl 7-hydroxy-8- 
nitrononanoate (82) which was purified by silica gel chromatography in a yield of 95%. The 
related compounds: ethyl 4-hydroxy-5-nitrohexanoate (83), methyl 6-hydroxy-7-
mtrooctanoate (84) and ethyl 8-hydroxy-9-nitrodecanoate (85) were synthesised in an 
analogous manner, with the yields shown in Table 3.6. Characterisation of compounds 82-85 
Mhairi I. Brunton 	 August 2003 
57 
Chapter 3 	 Nitroaldol Chemistry 
by 'H NMR confirmed the anticipated structures: the compounds typically showed an ethyl 
ester triplet at 1 .2ppm and quartet at 4. lppm (82, 83 & 85); a methyl ester singlet at 3.7ppm 
(84); a multiplet at 3.7-4.5ppm [-CH(OH)-], a multiplet at 4.5ppm [-CH(NO 2)CH3] and a 
doublet at 1.6ppm (-CHCH3). 
Table 3.6: Yields of nitroaldols 82, 83, 84 & 85 from the reaction of aldehydes 64, 80, 81 & 70 with 
nitroethane 
Compound 	 Structure 	 Yield (%) 	Overall Yield (%)* 
0 	 OH 
82 	 EtO. NO2 	95 	 66 
83 	 EtO4NO2 	 88 	
70# 
OH 
84 	 MeO).l(L NO 	89 	 71 
OH 
85 	E O 	 70 	 55 
OH 
* From starting acid, from ethyl succinyl chloride 






(64] 	 [86] 
Figure 3.16: Nitroaldol reaction of ethyl 7-oxoheptanoate (64) and nitrometharieto form ethyl 7-
hydroxy-8-nitrooctanoate (86) 
The nitromethane analogues of compounds 82-85: ethyl 7-hydroxy-8-nitrooctanoate (86, see 
Figure 3.16); ethyl 4-hydroxy-5-nitro pentanoate (87); methyl 6-hydroxy-7-nitro heptanoate 
(88); and ethyl 8-hydroxy-9-nitro nonanoate (89) were subsequently synthesised in the same 
manner as above, and the yields are shown in Table 3.7. The structures of compounds 86-89 
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Yield (%) 	Overall Yield (%)* 
0 	 OH 
86 	 92 	 63 
0 




88 	 MeO NO2 	 86 	 69 
OH 
0 
89 	EtO NO2 	82 	 65 
OH 
* From starting acid, # from ethyl succinyl chloride 
were also confirmed by 1 H NMR and each spectrum showed: an ethyl ester methyl triplet at 
Ca. 1 .2ppm (-Cl!3) and methylene quartet at Ca. 4. lppm (-CH2CH3) (86, 89 & 88)or a methyl 
ester singlet at 3.7ppm in the case of 87; and a multiplet at 4.6ppm (for the -CHOH & - 
CH2NO2 groups). 
By employing the method of Wollenberg and Miller the nitroalcohols 82-85 were formed in 
70-95% yield, giving acceptable overall yields in the range 55-71% from the starting acids 
(see Table 3.6). The yield of ethyl 8-hydroxy-9-nitrodecanoate (85) was low in comparison 
to the other compounds in the series: analysis of the reaction mixture by tic showed that this 
was due to partial decomposition of 85 by dehydration to the nitroalkene ethyl 9-
nitrodecenoate, a widely reported by-product of the mtroaldol reaction 139  The mtromethane 
analogue ethyl 8-hydroxy-9-nitro nonanoate (89) was synthesised with a reaction time of lh, 
and it can be seen in Table 3.7 that although this condensation has a lower yield than the 
other compounds in the series, the yield is higher than that experienced for the formation of 
85. The series of mtroketones 86-89 were synthesised in yields of 82-92%, giving overall 
yields of 63-72% fro the starting acids (as shown in Table 3.7). 
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3.4 Nitroketone Synthesis 
The next step required for the synthesis of AON, and related aminoketones was oxidation of 
nitro alcohols 82 -89 to the corresponding nitroketones. The majority of studies on the 
oxidation of nitroalcohols to mtroketones have used chromium (Vi) reagents. The earliest 
research by Levy and Scaife 172 and Hurd and Nilson 173  used sodium dichromate in sulfuric 
acid as the oxidant for the synthesis of simple a-mtroketones. Later research has used milder 
conditions such as PCC in dichioromethane at room em 	tur 174 It was found that this 
system gave good yields of a-nitroketones, typically 65%-87%, and that the conditions 
employed were mild enough to leave other functional or protecting groups unaltered. A 
drawback of this system are the long reaction times: typically 1.5 equivalents of PCC are 
added to the nitroalcohol in DCM and the mixture stirred for 24h at room temperature before 
addition of another 0.75 equivalents of oxidant and the mixture stirred for a further 12h. 
Oxidation of nitroalcohols has been carried out using phase transfer catalysis (PTC) 175 
Rosini eta! oxidised a series of nitroalcohols by the addition of potassium dichromate or 
potassium chromate in 30% sulfuric acid to a solution of the nitroalcohol and tetra-n-
butylammonium hydrogen sulfate (0. imol per mol nitroalcohol) in DCM. It was found that 
these reactions proceeded smoothly, giving good yields after 2h; the study also found that 
acid labile protecting groups were left intact. In subsequent studies Santaniello' 76 found that 
chromic acid (H2Cr04) supported on silica gel could be used for the oxidation of hydroxy 
compounds, however this catalyst has low stability and has not been used for the oxidation 
of mtroalcohols. In their study on the synthesis of nitroalcohols and mtroketones on solid 
support Mélot el al 169 found that although alumina supported Cr0 3 gave low yields of 
mtroketones from nitroalcohols, while montmorillonite K10 supported Cr0 3 gave simple 
nitroketones from nitroalcohols in good yields. The addition of the supported reagent to the 
nitroalcohol can cause spontaneous inflammation, but by adding the nitroalcohol to a 
suspension of montmorillomte reagent in DCM at -15°C they found that the exothermic 
reaction could be controlled to give yields of 76%-93% after 3.5h. A subsequent study by 
Ballini et a! 168 found that wet alumina supported Cr0 3 could be used for the in situ solvent 
free oxidation of supported nitroalcohols. Their procedure used neutral alumina to catalyse 
the formation of the desired nitroalcohol. 
On the basis of work by Ballini et a! and Mélot et alit was decided to carry out a series of 
trial reactions using both supported and solution phase chromium reagents for the oxidation 
of compounds 82-89. The first trial used wet alumina supported Cr0 3 168 added to 82, and 





although this method gave a reasonable yield of nitroketone it was found that the results 
were difficult to reproduce, and product isolation proved difficult. The second trial used 
montmorillonite supported chromium trioxide 169  which was added to 82 at -15°C. This 
method gave an acceptable yield of nitroketone (Ca. 60%), but again problems were 
experienced in extracting the product from solid oxidant. Trials using PCC and PDC in DCM 
gave good yields of nitroketone, however the most successful reagent proved to be Jones' 
reagent. It was therefore decided to use this as the method for the oxidation of compounds 
82-89. 
3.4.1 Synthesis of ethyl 8-nitro-7-oxononanoate (90) and related 
compounds 






) 	 2 
Figure 3.17: Jones' Oxidation of ethyl 7-hydroxy-8-nitrononanoate (82) to form ethyl 8-nitro-7- 
oxononanoate (90) 
Ethyl 8-nitro-7-oxononanoate (90) was synthesised by the Jones' oxidation of ethyl 7-
hydroxy-8-nitrononanoate (82, see Figure 3.17), affording after purification ethyl 8-nitro-7-
oxononanoate (90) in 91% yield. The related nitroketones: ethyl 5-nitro-4-oxohexanoate 
(91); methyl 7-nitro-6-oxooctanoate (92); and ethyl 9-nitro-8-oxodecanoate (93) were 
synthesised in an identical manner and the yields are shown in Table 3.8. Characterisation of 
the nitroketones 90, 91, 92 & 93 by 'H NMR showed the presence of all the desired 
functional groups: an ethyl ester triplet at Ca. 1 .2ppm (-CH3) and quartet at Ca. 4.Oppm (-
CH2-) (for 90, 91 & 93); methyl ester singlet at 3.7ppm (for 92); all four compounds showed 
a doublet at 1.6ppm (-CHCH3) and a quartet at 5.2ppm ( -CH(CH 3)NO2). 





Table 3.8: 	Yields of the nitroketones 90, 91, 92 & 93 from the Jones' oxidation of the corresponding 
nitroatcohols (82, 83, 84 & 85). 
Compound 	 Structure 	 Yield (%) 	Overall Yield (%)* 
0 	 0 
90 	 91 	 60 
91 	 Eto)1 .._/ y LNo 	 89 	 62# 
0 
92 	MeO__'f''LNO2 	88 	 62 
0 
87 	 48 
0 
* From starting acid, # from ethyl succinyl chloride 
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Figure 3.18: Jones' Oxidation of ethyl 7-hydroxy-8-nitrooctanoate (86) to form ethyl 8-nitro-7-
oxooctanoate (94) 
The nitromethane analogues of compounds 90-93:ethyl 8-nitro-7-oxooctanoate (94, Figure 
3.18); ethyl 5-nitro-4-oxopentanoate (95); methyl 7-nitro-6-oxoheptanoate (96); and ethyl 9-
nitro-8-oxononanoate (97) were synthesised in the same manner using the nitroalcohols 86, 
87, 88 & 89 as starting materials. 'H nmr characterisation of these compounds showed: the 
expected ethyl ester methyl triplet at Ca. 1 .2ppm (-CH3) and methylene quartet at Ca. 4. lppm 
(-CH2CH3) in compounds 94, 95 & 97; the methyl ester singlet at 3.7ppm in 96; and the (-
CH2NO2) singlet at ca. 5.3ppm in all four nitroketones. 






Table 3.9: 	Yields of the nitroketones 94, 95, 96 & 97 from the Jones' oxidation of the corresponding 
nitroalcohols (86, 87, 88 & 89). 
Compound 	 Structure 	 Yield (%) 	Overall Yield (%)* 
95 	 EO fNO2 	 67 
96 	 MeO '11 	 NO2 	
91 	 63 
97 	EtO'' f'NO2 	90 	 59 
* From starting acid, from ethyl succinyl chloride 
It has been shown above that although previous studies have oxidised nitroalcohols to 
nitroketones in good yield (61% or greater), the methods used have involved long reaction 
times, intricate procedures or supported reagents. By changing the oxidant for the reaction to 
Jones reagent the reaction procedure can be simplified and the yields improved. The reaction 
using Jones' reagent requires a simple titration of reagent onto a solution of the nitroalcohol 
in acetone, thus avoiding complex procedures, or extraction of the nitroketone product from 
a solid support. A further advantage in using Jones' reagent is the shortening of reaction 
times: with the substrates used the reaction time never exceeded lh. It can be seen in Table 
3.8 and Table 3.9 the yields for the Jones reagent mediated oxidation are not only higher, but 
the range of yields are narrower than previous studies (see above). Jones' reagent therefore 
provides a simple and high yielding method for the oxidation of mtroalcohols to 
nitroketones. 





3.5 Aminoketone & Aminoalcohol Synthesis 
The final step in the synthesis of AON and its related aminoketones and aminoalcohols was 
reduction of the nitro group of the parent mtroketones and nitroalcohols. In principle the 
reduction of aromatic intro compounds to amines can be effected under mild reaction 
conditions and without complication using a number of different reducing agents 177 
Although the mechanism has not been greatly studied it is presumed that that nitroso and 
hydroxylamine intermediates are involved (see Figure 3.19) 178  as treatment of these 
compounds with reducing agents gives amines. It has been suggested that the mechanism of 
metal and acid mediated reduction follows the pathway shown in Figure 3.19. 
o 	 o 
/ metal 
Ar— N + Ar—N+ 
O_ 	 o_ 
OH 	 OH 
.1 _______ 
Ar—N+ metal Ar—N 
O_ 
.. S.- 
Ar—O metal Ar—N-0 H 	Ar—N—OH 
metal 
Ar—N—OH 
S 	 . 	 .. 
H 
Ar—N—OH metal Ar—NH2 
.5 	 H+ 
Figure 3.19: Reduction of aromatic nitro compounds to amines 
A different problem lies in the reduction of aliphatic intro compounds, and a number of 
studies on their reduction have been 	rtak' 79  In preliminary studies it was found that 
the rate of reduction of aliphatic nitro compounds is considerably slower than that of 
aromatic intro compounds, and that the reaction products can poison the reduction 
catalyst 180  It was found that the successful reduction of aliphatic nitro compounds required 
high catalyst loading, vigorous conditions or long reaction im' 81 
The main obstacle in the reduction of nitro compounds comes not from the conditions 
required for the nitro reduction, but from the presence of other functional groups, which 
must be retained or reduced to afford the desired compound. Most hydrogenation catalysts 
were found to be unsuitable for the selective reduction of the nitro group of nitroketones, as 
they first reduce the carbonyl group, and often promote the cyclisation of the aminoketones 
formed It was found that the Mannich bases derived from p-mtroacetophenone could be 
successfully reduced to the corresponding aminoketones using 5% palladium on charcoal in 
methanol as the catalyst 182  The selective reduction of the nitro functional group in aromatic 
nitroketones is thought to be the result of preferential adsorption of the intro group to the 
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catalyst 181,  with cyclisation only occurring of the carbonyl and nitro groups are spatially 
proximate 183 
In 1986 Tamura el al found that hydrogenating ct-nitroketones over 5% platinum sulfide on 
carbon (Pt-S-C) effected the chemoselective reduction of the nitro group, forming an a-
aminoketone hydrochloride '. In a study of the scope of this reaction the group isolated a-
aminoketone hydrochlorides in good yields from a number of different a-nitroketone starting 
materials. It was therefore decided to use this method for the synthesis of 8-amino-7- 
oxononanoate (8) and its related compounds. 
3.5.1 Synthesis of 8-amino-7-oxononanoate (8) and related 
aminoketones 
pt-s-C EtO NO2 E 
	
- 0 	 NC1 
tOH/HCI 
-  
1901 	 (8] 
Figure 3.20: Synthesis of 8-amino-7-oxononanoate (8) from the reductive hydrogenation of ethyl 8-
nitro-7-oxononanoate (90) 
8-Amino-7-oxononanoate (8) was synthesised from ethyl 8-nitro-7-oxononanoate (90) using 
the method of Tamura et a1' (see Figure 3.20). Ethyl 8-nitro-7-oxononanoate (90) in 
ethanol-c.HC1 (20:1, v/v) was added to a suspension of 5% Pt-S-C in ethanol-c.HC1 (20:1, 
v/v) and the reaction mixture flushed with hydrogen three times before hydrogenation at 
50°C for 16h. After removal of the catalyst by filtration the crude aminoketone was taken up 
in aqHCl (SM) and stirred at 50°C for a further 4h to remove any residual ester protecting 
group. Purification of the crude product by ion exchange chromatography (DOWEX-50, H 
form) gave the desired product: 8-amino-7-oxononanoate (8) in 68% yield. The related 
compounds: 5-amino-4-oxohexanoate (98), 7-amino-6-oxooctanoate (99), and 9-amino-8-
oxodecanoate (100); were synthesised in the same manner using the corresponding a-
mtroketones. The yields of these are shown in Table 3.10. Characterisation of this series of 
compounds by 1 fl nnir confirmed the anticipated structures, with the presence of the methyl 
(-CH CH3) protons as a doublet at ca. 1.5ppm; the methine protons of the —COCH(CH 3)NIH2 
group as a quartet at Ca. 4. lppm; and the CH2CO2R and the CH2COR methylene protons as 
triplets at Ca. 2.2 and ca. 2.5 respectively. 





Table 3.10: Yields of the aminoketones 8, 98, 99 & 100 from the reduction of the corresponding 





Yield (%) Overall Yield (%)* 
8 	_O JL.__JL..J _NAC1 	58 	 35 
0 





—o NHC1 	 40 
0 
100 	O)L 	 (NHcl 	57 	 27 
0 
* From starting acid, 0 from ethyl succinyl chloride 
EtO _/lO2 




- Ojl'~~ N3 
[101] 
Figure 3.21: Synthesis of 8-amino-7-oxooctanoate (101) from the reductive hydrogenation of ethyl 8-
nitro-7-oxooctanoate (94) 
The nitromethane analogues of compounds 8, and 98-100: 8-amino-7-oxooctanoate (101, see 
Figure 3.21), 5-amino-4-oxopentanoate (102), 7-amino-6-oxoheptanoate (103), and 9-amino-
8-oxo nonanoate (104) were also synthesised according to the method of Tamura el al' 84  
using compounds 94-97 as starting materials. The yields of compounds 101-104 are shown 
in Table 3.11. Characterisation by 'H NMR confirmed the structures showing the expected 
splitting patterns: the methylene (-COCH 2NH3) singlet at Ca. 3.84.Oppm; and the methylene 
triplets (-CH2CO2R and - CH2COR) at Ca. 2.2 and 2.5ppm respectively. 





Table 3.11: Yields of the aminoketones 101, 102, 103 & 104 from the reduction of the corresponding 
nitroketones (94, 95, 96 & 97) 
Compound 	 Structure 	 Yield (%) 	Overall Yield (%)* 
101 Mt,61 	 67 	 40 
0 
102 	 01'fNPtC7I 	 70 	
47# 
0 
NC1 	 62 	 39 103 	 - 0 
0 
104 	
ON3C1 	 59 	 35 
0 
* From starting acid, # from ethyl succinyl chloride 
Table 3.10 and Table 3.11 above show that the reductive hydrogenation of compounds 90-97 
using the method of Tamura et aiiM  gives the desired a-aminoketone hydrochlorides (8, and 
98 - 104) in yields of 57 - 70%, giving an overall yield of 27 - 47 %. 
3.5.2 Synthesis of 8-am ino-7-hydroxynonanoate (106) and related 
aminoalcohols 





[10 51  
Figure 3.22: Synthesis of 8-amino-7-hydroxynonanoate (109) from the reductive hydrogenation of 
ethyl 7-hydroxy-8-nitrononanoate (82) 
With the successful development of a synthetic approach to a-aminoketones it was decided 
to extend this to the synthesis of the related a-aminoalcohols. To this end the aminoalcohol 
analogues of compounds 8, and 98-104 were synthesised from the a-nitroalcohols 82-89. 8-
aniino-7-hydroxy nonanoate (105, Figure 3.22) was synthesised from ethyl 7-hydroxy-8- 
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nitrononanoate (82) using the method of Tamura el aitM  as described above. Typically ethyl 
7-hydroxy-8-nitrononanoate (82) in ethanol-c. HC1 (20:1, v/v) was added to a suspension of 
5% Pt-S-C in ethanol-c.HC1 (20:1, v/v) and the reaction mixture flushed with hydrogen three 
times before hydrogenation at 50°C for 16h. The residual ester protecting group was 
removed after filtration of the catalyst by stirring in aqHCl (5M, 5cm 3) at 50°C for 4h. 
Purification of the crude product by ion exchange chromatography (DOWEX-50, H form) 
gave 8-amino-7-hydroxynonanoate in 69% yield. The related compounds: 5-amino-4-
hydroxyhexanoate (106); 7-amino-6-hydroxyoctanoate (107); and 9-amino-8-
hydroxydecanoate (108) were synthesised in the same way from compounds 83-89, and the 
yields are shown in Table 3.12. Characterisation of these compounds by 'H NMR showed 
the presence of the expected groups: the -CH 2CO2R methylene protons as a triplet at 
2.2ppm; the -CH2CH(OH)- methylene protons as a multiplet at Ca. 1.9ppm; the - CHOH and 
the -CH(CH3)NH2 methine protons as a multiplet at Ca. 4.3ppm; and the -CH(CH 3)NH2 
methane protons as a doublet at Ca. 1.4ppm. 
Table 3.12: Yields of the amir,oalcohols 105, 106, 107 & 108 from the reduction of the corresponding 
nitroalcohols (82, 83, 84 & 85). 
Compound 	 Structure 	 Yield (%) 	Overall Yield (%)* 
105 	_0. JL, 
	
03di 	69 	 46 
0 
106 	
ONCr 	 63 	
44# 
OH 
107 	O' NFCi 	 65 	 46 
OH 




* From starting acid, 0 from ethyl succinyl chloride 
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OH OH 
NO2 	Pt-S-C 	- 	 NHC1 
- 	 0 )("~~~ 3 
EtOH/HCI [86] 	 [109] 
Figure 3.23: Synthesis of 8-Amino-7-hydroxyoctanoate (109) from the reductive hydrogenation of ethyl 
7-hydroxy-8-nitrooctanoate (86) 
The nitromethane analogues of compounds 105-108: 8-amino-7-hydroxyoctanoate (109, 
Figure 3.23); 5-amino-4-hydroxypentanoate (110); 7-amino-6-hydroxyheptanoate (111); and 
9-amino-8-hydroxynonanoate (112) were synthesised in the same manner as above, using 
compounds 86-89 as starting materials. The yields of compounds 109-112 can be seen in 
Table 3.13. Characterisation of these compounds confirmed the expected structures showing 
the presence of: the -CH 2CO2H methylene protons as a triplet at Ca. 2.3ppm; the - 
CH2CH(OH)- methylene protons as a multiplet at Ca. 1 .8ppm; and the -CHOH- methine 
protons and the -CH2NH2 methylene protons as a multiplet at Ca. 4.5 ppm. 
Table 3.13: Yields of the aminoalcohols 109, 110, 111 & 112 from the reduction of the corresponding 
nitroalcohols (86, 87, 88 & 89). 
Compound Structure Yield 
Overall Yield (%) (%)* 
0 	 OH 
109 _0JJ_-...,-..,LNCI 	
68 	 43 
110 	 ONci 	 64 	 46 4  
OH 
111 	
ONCi 	 58 	 40 
OH 
0 
112 	O NHC1 	61 	 40 
OH 
* From starting acid, # from ethyl succinyl chloride 
The reduction of mtroalcohols to aminoalcohols is the most studied reduction of the aliphatic 
intro compounds, due to the importance of aniinoalcohols as biologically active compounds, 
and the resistance of the hydroxy group to reduction by the reagents used. A variety of 
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approaches to the synthesis of aminoalcohols have been adopted 179:  hydrogenation with 
Raney nickel, platinum oxide or palladium on barium sulfate to give aminoalcohols in yields 
of 80-95%; chemical reduction using a combination of metal and acid giving aminoalcohols 
in 92-98% yield; or electrochemical reduction using a lead cathode and dilute H 2 SO4 or HC1 
as the electrolyte forming aminoalcohols in yields of 75-94%. Table 3.12 and Table 3.13 
show that the method of Tamura et al 184 can be applied to the reduction of mtroalcohols, 
giving the desired aminoalcohols in yields of 58-69%. 
36 Conclusions 
The nitroaldol reaction, followed by oxidation of the nitroaldol product and reduction of the 
nitro group to an amine was investigated as a general approach to long chain aminoketone 
and aminoalcohol synthesis. 
Synthesis of the precursor aldehydes required for the nitroaldol reaction was achieved in 
good yield using the method of Four and Guibe' 67 (see section 3.2.4 pp.54). The desired 
aldehydes: ethyl 7-oxoheptanoate (64); ethyl 4-oxobutanoate (80); methyl 6-oxohexanoate 
(71); and ethyl 8-oxooctanoate (70) were synthesised in 74%, 80%, 83%, and 87% yield 
respectively. Reaction of these aldehydes with nitroethane and mtromethane in the presence 
of powdered potassium hydroxide according to the method of Wollenberg and Miller 171 gave 
the desired series of nitroalcohols via the nitroaldol reaction. Ethyl 7-hydroxy-8-
nitrononanoate (82); ethyl 4-hydroxy-5-nitro hexanoate (83); methyl 6-hydroxy-7-nitro 
octanoate (84); ethyl 8-hydroxy-9-mtrodecanoate (85); ethyl 7-hydroxy-8-nitrooctanoate 
(86); ethyl 4-hydroxy-5-nitropentanoate (87); methyl 6-hydroxy-7-nitroheptanoate (88); and 
ethyl 8-hydroxy-9-nitrononanoate (89) were synthesised in 95%, 88%, 89%, 70%, 92%, 
90%, 86% and 82% yields respectively. Oxidation of these nitroalcohols to the desired 
nitroketones was achieved using Jones' reagent. The mtroketones: ethyl 8-nitro-7-oxo 
nonanoate (90); ethyl 5-nitro-4-oxohexanoate (91); methyl 7-nitro-6-oxooctanoate (92); 
ethyl 9-nitro-8-oxodecanoate (93); ethyl 8-nitro-7-oxooctanoate (94); ethyl 5-nitro-4-oxo 
pentanoate (95); methyl 7-nitro-6-oxoheptanoate (96); and ethyl 9-nitro-8-oxononanoate (97) 
were synthesised in yields of 91%, 89%, 88%, 87%, 94%, 93%, 91%, and 90%. 
The hydrogenation method developed by Tamura et ailM  was designed for the reduction of 
mostly aromatic a-mtroketones to the corresponding a-aminoketone hydrochlorides. It has 
been shown above that this method can now be extended to non-aromatic nitroketones 
containing other functional groups. Table 3.10 and Table 3.11 show that the reductive 





hydrogenation of compounds 90-97 in the presence of 5% Pt-S-C and ethanolic HCI gives 
the desired a-aminoketone hydrochloride in yields of 57% or greater. 
The desired series of a-aminoketones: 8-amino-7-oxononanoate (8); 5-amino-4-oxo 
hexanoate (98); 7-amino-6-oxooctanoate (99); and 9-amino-8-oxodecanoate (100); 8-amino-
7-oxooctanoate (101); 5-amino-4-oxopentanoate (102); 7-amino-6-oxoheptanoate (103); and 
9-amino-8-oxononanoate (104) were prepared from their parent a-nitroketones using the 
method of Tamura el a! . Hydrogenation of the parent a-mtroketone in the presence of a 
partially poisoned platinum catalyst (5% Pt-S-C) and ethanolic HCL afforded the desired a-
aminoketones (8, and 98-104) in yields of 58%, 60%, 64%, 57%, 67%, 70%, 62 1/o, and 59%. 
The related o-aminoalcohols were synthesised in the same manner as above to extend the 
study of the interaction of these compounds with the 8-amino-7-oxononanoate synthase 
(AONS) and the 7,8-diaminononanoate synthetase (DANS) enzymes. 8-amino-7-hydroxy 
nonanoate (105); 5-amino-4-hydroxyhexanoate (106); 7-amino-6-hydroxyoctanoate (107); 9-
aniino-8-hydroxydecanoate (108); 8-amino-7-hydroxyoctanoate (109); 5-amino-4-
hydroxypentanoate (110); 7-amino-6-hydroxyheptanoate (111); and 9-amino-8-
hydroxynonanoate (112) were synthesised in 69%, 63%, 65%, 59%, 68%, 64%, 58%, and 
61% yields respectively from the hydrogenation of their parent a-nitroalcohols. 
It has been shown above that the nitroaldol reaction provides a excellent starting point for the 
synthesis of both a-aminoketones and ct-aminoalcohols. This method is advantageous as it 
allows variation in both the length of the desired amino compound, and the substitution 
between the amino and carbonyl or hydroxyl groups, thus providing a useful tool for binding 
studies involving the AONS and DANS enzymes. By using a synthetic pathway with a good 
deal of variability the range of compounds synthesised can be extended to include 
compounds suitable for use with other enzymes in the cx-oxoamine synthase family: 5-
aminolaevulinic acid synthase (ALAS); serine palmitoyl transferase (SPT); and 2-amino-3-
ketobutyrate CoA ligase (KBL). 
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Summary and Future Work 
4.1 Summary 
This work has been directed towards the development of new synthetic routes to 8-amino-7-
oxononanoate (8), an important intermediate in the biotin biosynthetic pathway. The routes 
developed had to be versatile to allow extension to analogues of AON which could be used as 
potential substrates or inhibitors of the 7,8-diaminononanoate synthetase enzyme. 
The first approach was the development of a synthetic route to 8 using Dakin-West chemistry, 
based on previous work in our laboratory 111 . To this end the oxazolone 2-methyl-4-phenyl 
oxazolone (40) was used as the starting point for the stepwise Dakin-West reaction, affording 
AON (8) as the final product in 4% overall yield. The low yield of 8 can be attributed to 
competing hydrolysis pathways (Figure 2.8, pp.34), since it might be anticipated that by 
changing the C-2 substituent on the oxazolone the hydrolysis could be directed along the 
desired pathway. Two oxazolones: 2,4-dimethyl oxazolone (43) and 2-methyl-4-trifluoromethyl 
oxazolone (46); were synthesised as intermediates. 2,4-Dimethyl oxazolone (43) afforded 8 in 
2% overall yield whilst 2-methyl-4-trifluoromethyl oxazolone (46) afforded 8 in 7% overall 
yield. The higher yield experienced using 46 as the initial oxazolone can be ascribed to the 
electron withdrawing effect of the trifluoromethyl C-2 substituent stabilising hydrolysis 
intermediates and promoting hydrolysis via Route A (Figure 2.8). In a further attempt to limit 
the competing hydrolysis routes experienced in the one pot ring opening and deprotection step 
an enzymatic ring opening of the C-acyl oxazolone using Lipozyme ® followed by a separate 
deprotection step to give AON (8) was investigated. Analysis of the purified products showed 
the major products to be dibutyl and monobutyl heptanedioate. This can be attributed to a 
number of factors: acid catalysis causing competing hydrolysis pathways; the nature of the C-
acyl C-4 substituent altering the rate of the enzymatic reaction; or the C-4 acyl group not being 
recognised or fitting into the active site of the enzyme. 
The nitroaldol reaction, followed by oxidation of the nitroaldol product and reduction of the 
nitro group to an amine was investigated as a general approach to a series of a-aminoketones 
and a-aminoalcohols. 
A series of aldehydes: ethyl 7-oxoheptanoate (64); ethyl 4-oxobutanoate (80); methyl 6-
oxohexanoate (81); and ethyl 8-oxooctanoate (70) were synthesised in good yield and used as 
the starting material for the nitroaldol reaction. This allowed the synthesis of eight a-
aminoketones: 8-amino-7-oxononanoate (8); 5-amino-4-oxo hexanoate (98); 7-amino-6-
oxooctanoate (99); and 9-amino-8-oxodecanoate (100); 8-amino-7-oxooctanoate (101); 5- 
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amino-4-oxopentanoate (102); 7-amino-6-oxoheptanoate (103); and 9-amino-8-oxononanoate 
(104) in overall yields of 35%, 37%, 40%,27%,40%,47%,39%, and 35%. The related a-
aminoalcohols: 8-amino-7-hydroxy nonanoate (105); 5-amino-4-hydroxyhexanoate (106); 7-
amino-6-hydroxyoctanoate (107); 9-amino-8-hydroxydecanoate (108); 8-amino-7-
hydroxyoctanoate (109); 5-amino-4-hydroxypentanoate (110); 7-amino-6-hydroxyheptanoate 
(111); and 9-amino-8-hydroxynonanoate (112) were synthesised in overall yields of 46%, 44%, 
46%, 32%, 43%, 46%, 40%, and 40%. It has been shown that the hydrogenation method 
developed by Tamura et al' for the reduction of aromatic nitroketones can be applied to 
aliphatic nitroketones and nitroalcohols, although the yields experienced are reduced. Tamura 
found that using a platinum catalyst over a palladium catalyst avoided the formation of 
aminoalcohols in aromatic systems as platinum has a lower affinity for the 7t-electrons of the 
aryl group, thus reducing the occurrence of carbonyl reduction. Although this factor is not as 
crucial in alkyl a-nitroalkyl ketones Tamura eta! found that 5% Pt-S-C was a more suitable 
catalyst than 5% Pd-C in all systems. A further study could use a palladium catalyst for the 
reduction of compounds 90-97 and compare the yields of a-aminoketone hydrochlorides 
synthesised. 
In summary the stepwise Dakin-West reaction and the nitroaldol reaction both allow the 
introduction of a high degree of variation in the a-aminoketones synthesised. However it has 
been shown that the Dakin-West reaction poses some problems in the final stages of the reaction 
sequence with the 1,3-dicarbonyl centres present causing competing hydrolysis routes. The 
nitroaldol reaction can be readily used to synthesise both a-aminoketones and a-aminoalcohols, 
and it is anticipated that these compounds can be used to probe the enzymes in the biotin 
biosynthetic pathway. 
4.2 Future Work 
Future work in this area can be divided into two main areas: development of the synthetic 
methods used and enzymatic studies to probe the AON analogues as potential substrates or 
inhibitors of the 7,8-dianiinononanoate enzyme. 
The Dakin-West chemistry could be further developed to overcome the problems experienced 
due to the competing hydrolysis routes resulting from the presence of the 1,3-dicarbonyl centre 
of the C-acyl oxazolone in compounds 42, 45 and 58. It has been reported in the literature that 
the use of acetic anhydride and pyridine, or anhydrous oxalic acid can prevent the competing 
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hydrolysis. In this instance the most suitable method to employ would be oxalic acid, as amino 
ketones form stable pyrazine salts in basic conditions. A second approach could be to reduce the 
side chain carbonyl group to the alcohol, ring opening and deprotection would then give the a-
aminoalcohol which could be readily oxidised to the cc-aminoketone. Trial reductions were 
carried out reducing 42 with sodium cyanoborohydride, achieving the alcohol in 85% yield. It is 
anticipated that this compound would be less susceptible to side reactions during hydrolysis, 
thus giving the desired ct-aminoalcohol in good yield. Selective oxidation of the secondary 
hydroxyl group could then be undertaken using Jones' reagent, giving the desired a-
aminoketones. Although this sequence would involve the addition of a reaction step, it is 
thought that this would be advantageous as hydrolysis would proceed more smoothly. 
With a robust synthetic route to AON established we can now undertake enzymatic studies on 
the, 7,8-diaminononanoate synthetasQ (DANS.) enzyme using the compounds synthesised. 
Enzymatic studies using AON would give greater insight intp the reaction mechanism of the 
enzyme. By repeating these studies using the other a-aminoketones and the ct-aminoalcohols 
synthesised we could examine their potential as substrates or inhibitors of the reaction. Here the 
a-aminoalcohols may prove useful as they cannot decarboxylate via the 0-keto acid route 
favoured by PLP dependant transaminases. 
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General Procedure 
All starting materials were purchased from commercial sources (Acros, Aldrich, Biorad, 
Fisher, Fluka, Nova Biochem, Pharmacia) and were used without further purification unless 
otherwise stated. 
Thin Layer Chromatography was carried out on aluminium sheets pre-coated with Merck 
silica gel 60 F254. Compounds were visualised by UV absorption, iodine staining, potassium 
permanganate (2% KMnO 4 in 2% NaHCO3) or ninhydrin dip (0.3% ninhydrin in EtOH-
collidine, 19:1). Silica gel chromatography was carried out using Matrex Silica 60 (particle 
size 35-70jim). 
Melting points were determined on an electrically heated Griffin melting point apparatus and 
are uncorrected. 
NMR spectra were recorded on a Varian Gemini 2000 (200MHz) or a Brucker AC250 
(250MHz) instrument. The chemical shifts () are given in ppm relative to tetramethylsilane, 
and the coupling constants (I) are in Hz. 
Fast Atom Bombardment mass spectra were recorded on a Kratos MS 50 TC instrument 
using glycerol, thioglycerol or NOBA as the matrix. Elecirospray lonisation mass spectra 
were recorded on a MicroMass platform II spectrometer with acetonitrile/water (50:50) as 
the solvent. 
Tetrahydrofuran was dried by reflux over sodiumlbenzophenone, distilled and stored over 
4A molecular sieves, or sodium wire. Dichioromethane was heated at reflux over calcium 
hydride, distilled and stored in the same manner. Triethylamine and diisopropylethylamine 
were dried by reflux over potassium hydroxide, distillation and were stored over calcium 
hydride. Toluene was distilled and stored over 4A molecular sieves. Jones Reagent was 
prepared by dissolving Cr03 (26g) in conc. H2SO4 (23cm). 
Organic extracts were routinely dried over anhydrous MgSO 4 and filtered prior to 
evaporation. 







Alanine (5.02g. 57mmol) was dissolved in 0.6M aqNaOH (20cm) and enough benzoyl 
chloride added to adjust the pH to 8. The mixture was cooled (4°C) and benzoyl chloride 
(8.35g, 59mmol) and aqNaOH (2M, "-30cin) added in tandem over 30 minutes to ensure a 
constant pH of 8-8.5. The cloudy solution was stirred at 4°C for 16h, conc.aqNaOH added 
(20cm3 , pHlO) and the solution extracted with EtOAc (3x50cm). aqHCl (10M) was added 
to adjust the pH of the solution to 2 and the solution extracted with EtOAc (3x50cm 3). 
Evaporation gave a colourless solid that was crystallised (aEtOH) to yield 39 (4.27g, 39%). 
mp = 150°C (lit 153  mp = 150-151 0C), M 193.17352 (C, 0H, 1NO3 requires 193.19924); 5H 
(200MHz, CDC13): 1.59 (3H, d, J=7.0 3-CH3); 4.78-4.85 (1H, q, J=7.0, 2-CH); 6.74 (1H, br. 
d, J=8.6, -NH); 7.42-7.82 (5H, m, 5 Ar-CH), öc (200MHz, CDC1 3): 16.7 (C-3), 50.7 (C-2), 
126.4, 128.5, 131.8 & 132.5 (6 x Ar-C), 169.1 (C-4), 180.3 (C- 1). All data compared 





36, (3.62g, 19mmol) was dissolved in acetic anhydride/dioxan (1:1, 28cm) and stirred with 
the exclusion of atmospheric water vapour (CaC1 2 drying tube) for lh at 50°C. The solution 
was cooled to room temperature and stirred for a further 1.5h. Removal of solvent, filtration 
through silica (ca.2g, eluting with DCM, 20cm) and evaporation gave a pale yellow oil that 
solidified on standing. The resultant solid was crystallised from ether to yield 40 (2.02g. 
62%). mp = 37°C (lit 124 37-390C); Vm (oil, cm') 1825 (CO2), 1649 (C=N); M 175. 18546 
(C 10H9NO2 requires 175.18396)5H(200MHz, CDC1 3): 1.55 (314, d, J=7.3, 4'-C}'13); 4.42(1H, 
q, J=7.5, 4-CH); 7.29-8.19 (511, m, Ar-H), 5H(200MHZ,  CDC13): 16.4 (C-4'), 125.6 (C-ipso), 
127.3 & 128.4 (4 x o-, rn-C), 132.1 (C-p), 160.9 (C-2), 179.2 (C-5). All data compared 
favourably to samples synthesised previously in this laboratory 





Methyl 6-ch lorocarbonyl hexanoate (41) 
Oxalyl chloride (7.615g. 60mmol) was added drop-wise to monomethyl heptanedioic acid 
(5.225g, 30mmol) in dry DCM (20 cm). The resulting solution was stirred under N 2 for lii, 
heated to 50°C and stirred for a further 1.5h. Excess solvent was removed in vacuo and the 
oil distilled to afford 41 (5.493g, 95%). bpo .4 = 87°C, oH (200MHz, CDC1 3): 1.32-1.44 
(2H, m, 4-CH2); 1.54-1.78 (4H, m, 3,5-CH2); 2.28 (211, t, J=73 2-CH2); 2.86 (2H, t, J=73, 
6-CH2); 3.48 (3H, s, i'-CH3); 0c  (200MHz, CDC13): 24.5 (C-3), 24.7 (C-4), 27.3 (C-5), 33.4 
(C-6), 46.4 (C-2), 60.5 (C- F), 173.2 (C- 1), 173.5 (C-7). All data compared favourably to 
samples synthesised previously in this laboratory". 
Methyl, 4-methyl-2-phenyl-oxazol-5-yl heptanedioate (42) 
Ph 
0:( )~~~0100_ 
38 (293mg, 1 .52mmol) was added drop-wise to a cooled (4°C) solution of 37(273mg, 
1.57mmol) and Et3N (147mg, 1.45mmol) in dry THF (5cm). The reaction mixture was 
stirred under N 2 for 16h at RT. The excess solvent was removed in vacuo and ether (15 cm) 
added. The organic layer was washed with aqHCl (0.3M, 2x 15 cm), and water (15 cm), 
dried and evaporated to a pale yellow oil. Silica gel chromatography (20g, hexane/ethyl 
acetate, 4:1) afforded 41 (566mg, 74%)as a colourless oil. M = 33 1.14182 (C 18H2,N05 
requires 331.14197); 0H  (200M}Iz, CDC13): 1.46 (211, m, 4-CH2); 1.71 (414, m, 3,5-CH2); 
2.08 (3H s, 4"-CH3); 2.36 (211, t, J=7.3, 6-CH2); 2.64 (2H, t, J=7.5, 2-CH2); 3.68 (3H, s, 1'-
CH3); 7.40-7.95 (5H, m Ar-H); 0c  (200MHz, CDC13): 9.9 (C-4'), 23.9, 24.2, 28.5 (C-7', -8', 
-9'), 33.3, 33.6 (C-6', -10'), 50.9 (C-12'), 120.5 (C-ipso), 125.4, 128.3 (4 x C-o, -m), 127.2 
(C-4), 129.9(C-p), 145.1 (C-5), 154.4 (C-2), 170.0 (C-5'), 173.9 (C-il'). All data compared 
favourably to samples synthesised previously in this laboratory 





7-(4-methyl-5-oxo-2-phenyl-oxazol-4-yl)-methyl 7-oxo-heptanoate (43) 
Ph 
DMAP (7.0mg, 64.7tl) was added to a solution of 42 (389mg, 1.08 mmol) in dry THF 
(7cm3). The solution was stirred under N2 at room temperature for 16h, solvent removed in 
vacuo, and the product dissolved in ether (15cm 3). The organic phase was washed with 
aqHCl (0. 1M, 2x 15cm), water (15cm) and brine (15cm), dried and evaporated to a yellow 
oil. Silica gel chromatography (20g, hexane/ethyl acetate, 4:1) afforded 43 as a colourless oil 
(263mg 68%). M 33 1.14175 (C 18H21N05 requires 331.14197); 8H  (200MHz, CDC13): 1.24 
(21-1, m, 8'- CH2); 1.58 (41-1, m, 7',9'-CH2); 1.70 (31-1, s, 4'-CH 3); 2.27 (2H, t, J=7.5, 5'-CH2); 
2.55 (2H, t, J-5.8, 10'-CH2); 3.56 (31-1, s, 12'-CH 3); 7.52-8.07 (51-1, m, Ar-H); 6c  (200MHz, 
CDC13): 9.9 (C-4'), 23.9, 24.2, 28.5 (C-7', -8', -9'), 33.3, 33.6 (C-2', -10'), 50.9 (C-l'), 84.6 
(C-4), 120.5 (C-ipso), 125.4, 128.3 (4 x C-o, -m), 127.2 (C-4), 129.9 (C-p), 145.1 (C-5"), 
154.4 (C-2), 170.0 (C-1 F), 173.9 (C-5'). All data compared favourably to samples 
synthesised previously in this laboratory 
8-Amino-7-oxo-nonanoate hydrochloride (8) 
HOJL
J'( NFCi 
43 (117mg, 324.7p.mol) was dissolved in aqHCl (4M, 10cm), and the solution stirred at 80° 
C for 24h. The reaction mixture was cooled to RT, washed with DCM (3x3cm 3) and the 
aqueous phase evaporated to dryness. Ion exchange chromatography (DOWEX-SOX, H 
form, eluting from 0-1M HC1), and crystallisation of the resultant solid from ethanol/ether 
afforded 8(10mg, 13.8%). Rf= 0.45 (butanollacetic acid/water, 3:1:1); Vmax (nujol, cm') 
3134 & 3040 (NH3 & COOH), 1754 (COOH); MH: 188. 12882 (C9H 18NO3 requires 
188.12867); 6H  (200MHz, D20): 1.19 (21-1, m, 4-CH 2); 1.39 (31-1, d, J=7.4, 9-CH3); 1.45 (41-I, 
m, 3,5-CE!2); 2.22 (21-1, t, J=7.3, 2-CH2); 2.52 (21-1, t, J=7.3, 6-CH2); 4.10 (11-1, q, J=7.5, 8-
CH); 5c (250MHz, D20): 14.6 (C-9), 22.2, 23.9, 27.5 (C-3, -4, -5) 33.7 (C-2), 37.8 (C-6), 
54.8 (C-8),179.0 (C-i), 209.3 (C-7). 





2,4-dimethyl oxazolone (44) 
0 Z_ 
N-acetyl alanine (1.007g, 7.6mmol) was dissolved in dry THF (15cm) and DCC (1.691g, 
8.2mmol) added portion-wise. The solution was stirred with the exclusion of water (CaC1 2 
drying tube) for 2h at RT. Solvent was removed in vacuo, DCM (15 cm)added and the 
suspension was filtered to remove DCU. Evaporation of the filtrate gave an oil that solidified 
on standing. Crystallisation from ether afforded 44 (497mg, 57.8%) as a colourless solid. mp  
= 35°C, 6H  (200MHz, CDC13): 1.46 (3H, d, J=7.7, 4'-CH3); 2.21 (3H, s, 2-CH3); 4.18 (1H, 
in, 4-CH); 8c (200MHz, CDC13): 12.2 (C-4'), 15.3 (C-2'), 28.3 (C-4), 130.4 (C-2), 172.3 (C-
5). 
Methyl, 2,4-dimethyloxazol-5-yl heptanedioate (45) 
----e T° 0j",'~0"- 
41 (293mg, 1 .52mmol) was added drop-wise to a cooled (4°C) solution of 44 (184mg, 
1.63mmol) and Et3N (147mg, 1.45mmol) in dry THF (5cm). The reaction mixture was 
stirred under N2 for 16h at room temperature before removal of excess solvent in vacuo and 
addition of ether (15cm). Washing with aqHCl (03M, 2x15cm 3), and water (15 cm), drying 
and evaporation gave a pale yellow oil. Silica gel chromatography (20g, hexane/ethyl 
acetate, 4:1) afforded 45 (293mg, 64%) as a colourless oil. M 269.12669 (C 131119N05 
requires 269.12632); 5H  (200MHz, CDC13): 1.45 (211, in, 4-CH2); 1.67 (4H, m, 3,5-CH2); 
1.97 (3H, s, 2"-CH3); 2.07 (3H, s, 4"-CH3); 2.32 (211, t, J=7.3, 6-CH2); 2.61 (2H, t, J=7.3, 2-
CH2); 3.64 (3H, s, 1'-CH 3); 6c  (200MHz, CDC13): 9.9 (C-4'), 15.3 (C-2'), 23.9, 24.2, 28.5 
(C-7', -8', -9'), 33.3, 33.6 (C-6', -10'), 50.9 (C-12'), 127.2 (C4),145.1 (C-5), 154.4 (C-2), 
170.0 (C-5'), 173.9 (C-li'). 





7-(2,4-dimethyl-5-oxo-oxazol-4-yl)-methyl 7-oxo-heptanoate (46) 
0 T_ I 
DMAP (10mg, 81.9j.tmol) was added to a solution of 45(508mg, 1.79mmol) in thy 11-IF 
(10cm) and the solution stirred under N 2 at room temperature for 16h. Excess solvent was 
removed in vacuo and the product taken up in ether (15cm). The organic layer was washed 
with aqHCl (0. 1M, 2x 15cm), water (15cm) and brine (15cm 3), dried and evaporated to a 
pale yellow oil. Silica gel chromatography (hexane/ethyl acetate, 4:1) afforded 46(244.9mg, 
48.2%)as a colourless oil. ö (200M11z, CDC1 3): 1.45 (2H, m, 4-CH2); 1.67 (4H, m, 3,5-
CH2); 1.76 (3H, s, 4"-CH 3); 1.97 (3H, s, 2"-CH 3); 2.29 (211, t, J=7.3, 6-CH2); 2.59 (2H, t, 
J=7.3, 2-CH); 3.64 (311, s, 1'-CH 3); 8C (200MIHz, CDC13): 9.9 (C-4'), 15.3 (C-2'), 23.9, 
24.2, 28.5 (C-7', -8', -9'), 33.3, 33.6 (C-6', -10'), 50.9 (C-12'), 82.3 (C-4),145.1 (C-5), 
154.4 (C-2), 170.0 (C-5'), 173.9 (C-1 I'). 
8-am i no-7-oxononanoate hydrochloride (8) from 46 
HO.J
JL( NECt 
46(247.9mg, 875.Opmol) was dissolved in 2M aqHCl (5cm 3), and the solution stirred at 80° 
C for 8h, before being cooled to RT and stirred for a further 12h. The mixture was extracted 
with DCM (3x4cm3) and the aqueous phase evaporated to dryness. The solid was dissolved 
in water (0.5cm), purified by ion-exchange chromatography (DOWEX-50X, H form, 
eluting with HC1, 0-i M) and crystallised (ethanol/ether) to give 8 as its HC1 salt (2 0mg, 
10%). For data see 8-Amino-7-oxo-nonanoate hydrochloride (8), pp. 79 
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L-alanine (996mg, 1 immol) was added to trifluoroacetic anhydride (5.35g, 26mmol) and the 
resulting solution was stirred at 140°C for 2h. The mixture was cooled to RT, Bu 3N (11mg, 
56pmol) added and distilled to yield 47(1.79g, 96%) as a pale yellow oil. bp 20,,,,, =34 1C 127 
H (200MHz, CDC13) 2.41 (311, s, 4'-CH 3), 6.08 (111, br s, 2-CH). Proton nmr compared 
favourably to  literature 127 .  
Methyl, 4-methyl-2-trifluormethyloxazol-5-yI heptanedioate (48) 
F3C..N T 
41 (293mg, 1.52nimol) was added drop-wise to a cooled (4°C) solution of 47 (242mg, 
1.45mmol) and Et3N (147mg, 1.45mmol) in dry THF (5cm). The reaction mixture was 
stirred under N2 for 16h at room temperature before removal of excess solvent in vacuo and 
addition of ether (15cm 3). The crude solution was washed with aqHCl (03M, 2x15cm), and 
water (15 cm), dried and evaporated to a pale yellow oil. Silica gel chromatography (20g, 
hexane/ethyl acetate, 4:1) afforded 48 (262mg, 65%)as a colourless oil. 6H  (200Mhz, 
CDC13): 1.35 (211, m, 4-CH2); 1.60 (411, m, 3,5-CH2); 2.10 (3H, s, 4"-CH3); 2.25-2.38 (411, t, 
J=7.2, 2,6-CH2); 3.68 (311, s, 1'-CH3); öc (200MHz, CDC13): 10.4 (C-4'), 23.6, 24.5, 28.6 
(C-7', -8', -9'), 33.2, 33.4 (C-6', -10'), 50.9 (C-12'), 121.1 (C-2'), 127.2 (C-4), 145.1 (C-5), 
154.4 (C-2), 170.0 (C-5'), 173.9 (C-il'). 
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DMAP (9mg, 70j.tmol) was added to a solution of methyl, 48 (406mg, 1.25mmol) in dry 
TI-IF (7cm3) and the solution stirred under N 2 at room temperature for 16h. After removal of 
solvent in vacuo the product was dissolved in ether (15 cm)and washed with aqHCl (0. 1M, 
2x 15cm), water (15cm3) and brine (15 cm), before drying and evaporation to a pale yellow 
oil. Silica gel chromatography (hexane/ethyl acetate, 4:1) afforded 49 (262mg, 65%)as a 
colourless oil. oH (200M}Iz, CDC13): 1.33 (2H, m, 4-CH 2), 1.63 (411, m, 3,5-CH2), 1.74 (3H, 
s, 4'-CH3), 2.35 (4H, t, J=7.1, 2,6-CH2), 3.66 (311, s, 12'-CH3); 0c  (200MIHz, CDC13): 9.9 
(C-4'), 23.9, 24.2, 28.5 (C-7', -8', -9'), 33.4, 33.8 (C-6', -10'), 60.4 (C-12'), 82.7 (C-4), 
124.3 (C-2'), 145.1 (C-5), 154.7 (C-2), 171.5 (C-5'), 173.3 (C- 11'). 





49 (130mg, 402 j.tmol) was dissolved in 3M aqHCl (5cm3), and stuffed at 80°C for 24h. The 
solution was cooled, extracted with DCM (3x4cm 3) and the aqueous phase evaporated to 
dryness. Purification by ion-exchange chromatography (DOWEX-50, H form, eluting with 
HCI, 0-1M) and crystallisation (ethanol/ether) afforded 8 as its HC1 salt (15mg 17%). For 
data see 8-Amino-7-oxo-nonanoate hydrochloride (8), pp.  79 
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Chapter 5 	 Experimental 
Lipase Ring opening of 43 
43 (20mg, 60.4pmol) was added to a suspension of n-butanol (8.2mg, 0. l2mmol), Et 3N 
(1.87mg, 18.5pmol) and Lipozyme® (20mg) in dry toluene. The reaction mixture was shaken 
on an orbital shaker at 200rpm. 37°C for 72h. Lipozyme ® was removed by filtration and 
solvent evaporated under reduced pressure to give a pale yellow oil. The crude product was 
purified by preparative layer chromatography (plc), eluting with hexane/ether (1:1) to yield 
dibutyl heptanedioate (8mg, 48.5%) as a colourless oil. 6H  (200MHz, CDC13): 0.92 (6H, t, 
J=7.3, 4',4"-CH3); 1.38 (6H, m, 4,3',3"-CH2); 1.60 (81-1, m, 3,5,2'2" -Cl-I2); 2.29 (41-1, t, 
J=7.4, 2,6-Cl-I2); 4.06 (4H, tJ==6.6, 1',1"-CH2) 
Lipase ring opening of 46 
46(20mg, 74p.mol) was dissolved in dry toluene (3cm) and n-butanol (11mg, 140p.mol), 
Et3N (2mg, 19pmol) and Lipozyme® (20mg) added. The solution was shaken on an orbital 
shaker at 200rpm, 37°C for 72h. Lipozyme ® was removed by filtration and solvent 
evaporated under reduced pressure to give a pale yellow oil. The crude product was purified 
by plc, eluting with hexane/ether (1:1) to yield dibutylpimelate (8mg, 40%) as a colourless 
oil. For data see Lipase ring opening of 43 (above). 
Lipase ring opening of 49 
49(20mg, 62pmol) was added to a suspension of n-butanol (9mg, 11 Opmol),  Et 3N (2mg, 
19pmol) and Lipozyme® (20mg) in dry toluene (3cm). The suspension was shaken on an 
orbital shaker at 200rpm, 37°C for 72h. Lipozyme ® was removed by filtration and solvent 
evaporated under reduced pressure to give a pale yellow oil. The crude product was purified 
by plc, eluting with hexane/ether (1:1) to yield dibutylpimelate (10mg, 53%) as a colourless 
oil. For data see Lipase ring opening of 43 (above). 
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Chapter 5 	 Experimental 
Ethyl 7-hydroxyheptanoate (66) 155 
­-~O)~~~~~OH 
Potassium persulfate (32.5g, 120mmol) was added gradually to a cooled (15°C) solution of 
H2SO4 (96%, 0.55mo1, 31cm), water (0.55mo1, 10cm) and ethanol (24cm 3) and stirred for 
0.5h. Cycloheptanone (4.487g, 40mmol) in ethanol (16cm) was added drop-wise at 15°C, 
and reaction mixture stirred at room temperature for 16h. The solution was diluted with 
water (240cm), extracted with Et 20 (3x80cm3) dried and evaporated to give a pale yellow 
oil. Purification by silica gel chromatography (20g, hexane/Et 20, 1:1) afforded ethyl 7-
hydroxyheptanoate (66, 1,702g, 24%) as a colourless oil. M 174.22543 (C9H 1 803 requires 
174.22567); 5H  (200MHz, CDC13): 1.21 (3H, t, J=7.2, 2'-CH3); 1.34 (4H, in, 4,6-CH2); 1.59 
(4H, m, 3,5-CH2); 2.26 (2H, t, J=7.5, 2-CH2); 3.59 (2H, t, J=6.5, 7-CH2); 4.10 (211, q, 
J=7.0, 1'-CH2); öc (200MHz, CDC1 3): 14.1 (C-2'), 24.5 (C-4), 28.3, 28.6 (C-3, -5), 33.9 (C-
2), 38.9 (C-6), 60.2, 63.2 (C- F, -7), 173.5 (C- 1). Data compared favourably to literature '. 
Ethyl 8-hydroxyoctanoate (67) 
OH 
Using the procedure described above ethyl 8-hydroxyoctanoate (67) was synthesised from 
potassium persulfate (44g, 1 SOmmol), H2SO4  (96%, 0.7mol, 3 9cm), water (0.7mol, 13cm), 
ethanol (56cm) and cyclooctanone (6.3g, 50mmol) in 37% yield (3.5g). Rf= 0.46 (1:1, 
hexane/ether); M 188.14129 (C 10H2003 requires 188.14133); 5H  (200M11z, CDC13): 1.21 
(314, t, J=7.1, 2'-CH3); 1.30 (6H, m, 4,5,6-CH2); 1.58 (411, in, 3,7-CH2); 2.25 (2H, t, J=7.5, 
2-CH2); 3.59 (2H, t, J=6.6, 8-CH2); 4.09 (2H, q, J=7.1, 1'-CH2); ö (200MHz, CDC1 3): 14.6 
(C-2'), 24.5, 25.2 (C-4, -5), 28.6, 28.9 (C-3, -6), 32.8 (C-2), 39.5 (C-7), 60.9, 63.4 (C- 1', -8), 
174.1 (C-i) 





Ethyl 6-hydroxyhexanoate (68) 
jJ. OH 
Using the procedure described above ethyl 6-hydroxyhexanoate (68) was synthesised from 
potassium persulfate (32.4g. 0. l2mol), H2SO4  (96%, 0.56mo1, 31cm), water (0.56mol, 
10cm), ethanol (45cm) and cyclohexanone (3.93g, 40mmol) in 44% yield (2.84g). Rf= 
0.45 (1:1 hexane/EtOAc); M 160.11014 (C 8H1603 requires 160.11001); 8H  (200MiHz, 
CDCI3): 1.16 (311, t, J=7.1, 2'-CH3); 1.31 (4H, q, 4-CH2); 1.53 (411, m, 3,5-CH2); 2.22 (211, 
t, J=7.3, 2-CH); 3.53 (2H, t, J=6.4, 6-CH2); 4.03 (211, q, J=6.6, 1'-CH2); & (200MHz, 
CDC13): 13.7 (C-2'), 27.9, 28.4 (C-3, -4), 32.8 (C-2), 39.2 (C-5), 61.0, 64.5 (C- F, -6), 174.0 
(C-i). 
Ethyl 5-hydroxypentanoate (69) 
0 
Using the procedure described above ethyl 5-hydroxypentanoate (69) was synthesised from 
potassium persulfate (32.5g. 0. l2mol), H2SO4  (96%, 0.56mo1, 31cm3), water (0.56mo1, 
10cm), ethanol (45cm) and cyclooctanone (3.37g, 40mmol) in 28% yield (1.64g). Rf= 0.52 
(1:1, hexane/ether); M 146.09461 (C 7H1403 requires 146.09435); 5H  (200MHz, CDC13): 
1.19 (3H, t, J=7.1, 2'-CH3); 1.62 (2H, m, 3,4-CH2); 2.28 (2H, t, J=7.1, 2-CH2); 3.57 (2H, t, 
J=5.9, 5-CH); 4.06 (2H, q, J==7.4, 1'-CH2); 8c (200MHz, CDC13): 14.4 (C-2'), 28.9 (C-3), 
32.2 (C-2),38.5 (C4), 61.5, 64.6 (C- F, -5), 173.6 (C- 1). 13-C mnr data compares 
favourably to literatur 186e 





Ethyl 7-oxoheptanoate (64) via Oxidation of 66 155 
Ethyl 7-hydroxyheptanoate (66, 523mg, 3mmol) in DCM (2cm) was added drop-wise to 
PCC (1.94g. 9mmol) in DCM (7cm). The suspension was stiffed at room temperature for 3h 
before dilution with ether (20cm) and filtration through Celite. Evaporation of the solution 
gave an orange oil which was purified by silica gel chromatography (20g. hexane/EtOAc, 
2:1) to yield ethyl 7-oxoheptanoate (64, 215mg, 42%). M 172.11057 (C 9H1603 requires 
172.11001); 6H  (200M1-Iz, CDC1 3): 1.20 (3H, t, J=7.1, 2'-CH3); 1.32 (2H, m, 4-CH2); 1.60 
(4H, m, 3,5-CH2); 2.27 (2H, t, J=7.5, 2 -CH2); 2.28 (2H, t, J=7.3, 6-CH2) 4.06 (2H, q, J=7.2, 
1'-CH2); 9.82 (1H, s, 8-CH); öc (200MHz, CDC1 3): 14.0 (C-2'), 21.5 (C-3), 24.1 (C-4), 24.4 
(C-5), 28.3 (C-6), 43.5 (C-2), 60.1 (C-l'), 173.5 (C-i) 202.5 (C-7). Data compared 
favourably to literature 155 .  
Ethyl 8-oxooctanoate (70) via Oxidation of 67 
Ethyl 8-oxooctanoate (70) was synthesised in the same manner as above using ethyl 8-
hydroxyoctanoate (67, 0.57g, 3mmol) and PCC (1.94g, 9mmol) in DCM (5cm) in a yield of 
61% (0.34g). Rf=0.61 (2:1, hexane/EtOAc); M 186.12579 (C 10H1803 requires 186.12567); 
H (200MHz, CDC13): 1.31 (3H, t, J=7.2, 1'-CH2); 1.40 (4H, m, 4,5-CH2); 1.69 (411, m, 3,6-
CH2); 2.35 (2H, t, J=7.4, 2-CH2); 2.48 (2H, t, J=7.2, 7-CH2); 4.18 (2H, q, J=7.2, 1'-CH2); 
9.82 (1H, s, 8-CH); 8 c (200MHz, CDC1 3): 13.7 (C-2'), 21.2 (C-4),22.3 (C-5), 23.9 (C-3), 
24.4 (C-6), 28.3 (C-2), 42.9 (C-7), 60.4 (C- 1'), 174.3 (C- 1)200.9 (C-8) 










Ethyl 6-oxohexanoate (71) was synthesised in the same manner as above using ethyl 6-
hydroxyhexanoate (68, 1.06g. 6.6mmol) and PCC (4.27g, 20mmol) in DCM (11cm) in a 
yield of 40% (415mg). Rf= 0.53 (3:2, hexane/EtOAc); M 158.09429 (C811 1403 requires 
158.09435); 6H  (200MHz, CDC13): 1.23 (311, t, J=7.1, 2 1 -CH3); 1.62 (411, in, 3,4-CH2); 2.27 
(211, t, J=7.3, 2 -CH2); 2.41 (211, t, J=7.3, 5-CH2) 4.10 (211, q, J=7.1, i'-CH2); 9.74 (111, s, 
6-CHO); 5c (200M14z, CDC1 3): 14.5 (C-2'), 24.5 (C-3), 24.9 (C-4), 28.7 (C-2), 43.0 (C-5), 
60.7 (C- F), 172.9 (C- 1) 201.5 (C-6) 
Ethyl 5-oxopentanoate (72) via Oxidation of 69 
H 
Ethyl 5-oxopentanoate (72) was synthesised in the same manner as above using ethyl 5-
hydroxypentanoate (69, 281mg, 1 .9mmol) and PCC (1.23g. 5 .7mmol) in DCM (3cm3) in a 
yield of 21% (57mg). Rf= 0.38 (2:1 hexane/EtOAc); M 144.07892 (C 7H1203 requires 
144.07869); oH (200MHz, CDC13): 1.12 (311, t, J=7.1, 2'-CH3); 1.54 (2H, in, 3-CH2); 2.33 
(211, t, J=6,5, 2-CH2); 2.50 (21-1, t, J=7.1, 4 -CH2); 3.99 (211, q, J=7.3, 1'-CH 2); 9.64 (1H, s, 
5-CIIO); 8c (200MHz, CDC13): 14.5 (C-2'), 24.6 (C-3), 28.1 (C-2), 42.4 (C-4), 61.4 (C- F), 
173.0 (C-i) 200.6 (C-5) 
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Ethyl 7-oxoheptanoate (64) via hydrogenation of 71 162 
Ethyl 6-chiorocarbonyihexanoate was added to a pre-hydrogenated suspension of 
diisopropylethylamine (300mg, 2.4mmol) and Pd-C (10%, 200mg) in acetone (10cm). The 
reaction mixture was hydrogenated for 3h before filtration of the catalyst and dilution of the 
filtrate with aqHCl (2M, 10cm 3). Extraction with hexane, drying (MgSO 4) and evaporation 
afforded a pale yellow oil that was distilled to yield ethyl 7-oxoheptanoate (61, 8 8mg, 21%). 
For data see Ethyl 7-oxoheptanoate (64) via Oxidation of 66 155 pp.87. 
64 via sodium tri-t-butoxyalumi nohyd ride reduction of 71 158 
'.--~O)Ll' 	~ H 
Sodium tri-I-butoxyaluminohydride was prepared by stirring sodium aluniimum hydride 
(5.4g, lOOmmol) in diglyme (120cm3, dried over NaOH) for 24h. The resulting suspension 
was filtered under N2 and the filtrate added to 'BuOH and stirred under N 2 for 6h at 0°C. 
Sodium In-t-butoxyaluniinohydride (40cm 3, 16mmol, 0°C) was added drop-wise to a 
solution of ethyl 6-chlorocarbonyihexanoate (3.00g, 14. 5mmol) in dry THF (14.5cm) at - 
78°C. The reaction mixture stirred for 1 .5h at -78°C and warmed to room temperature. 
aqHCl (1M, 40cm) added and extracted with EtOAc (3x30m1) evaporation gave an oil that 
was washed with water (300cm) to remove digylme. Drying (MgSO 4) and evaporation 
gave a colourless oil, purified by column chromatography (30% EtOAc in hexane) to give 
ethyl 7-oxoheptanoate (64, 667mg, 27%). For data see Ethyl 7-oxoheptanoate (64) via 
Oxidation of 66 pp. 87 . 
Acid Chloride Synthesis - General Procedure 
Oxalyl chloride (2 equivalents) was added dropwise to a solution of a diacid monoester in 
dry DCM. The resulting solution was stirred under N 2 for lh, heated to 50°C and stirred for a 
further 1.5h. Excess solvent was removed in vacuo and the oil distilled to afford the desired 
acid chloride. 
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Ethyl 6-chiorocarbonyl hexanoate (74) 
cl 
71 was prepared as for the general procedure (pp.89) using oxalyl chloride (2.539g, 
20mmol), monoethyl heptanedioic acid (1.882g, 1 Ommol) and dry DCM (20 cm) in a yield 
of 1.922g (93%). bp0.mm = 90°C; M 206.55501 (C91-1 15030 requires 206.555 18); oH 
(200MHz, CDC13): 1.20 (31-1, t, J=7.5, 2'-CH3); 1.32-1.44 (2H, m, 4-CE! 2); 1.54-1.78 (4H, m, 
3,5-CH2); 2.28 (2H, t, J=7.3 2-CH2); 2.86 (21-, t, J=7.3, 6-CH2); 4.10 (21-, q, J=7.2, 1'-
CH2); 0c  (200MHz, CDC13): 14.0 (C-2'), 24.2 (C-3), 24.5 (C-4), 27.7 (C-5), 33.7 (C-6), 46.7 
(C-2), 60.2 (C- F), 173.2 (C- 1), 173.5 (C-7). 
Methyl 5-chiorocarbonyl pentanoate (78) 
Cl 
0 
78 was prepared analogously to the general procedure(pp.89) using oxalyl chloride (2.539g. 
20mmol), monomethyl hexanedioic acid (1.602mg, lOmmol) and dry DCM (10cm) in a 
yield of 1.715g (96%). bpø.ø5mm = 50°C (Lit 187 bpo.imm = 61 0C); M: 178.52367 (C7H11 03 C1 
requires 178.52386); 0H  (200MHz, CDC13): 1.77 (211, m, 3-CE!2); 1.80 (211, m, 4-CE!2); 2.41 
(211, t, J=6.8, 2-CH2); 2.99 (2H, t, J=7.0 5-CH2); 3.74 (311, s, i'-CH 3) ; 0c (200MHz, 
CDC13): 24.5 (C-3), 27.7 (C-4), 33.7 (C-6), 46.7 (C-2), 61.4 (C- 1'), 172.8 (C- 1), 173.3 (C-6). 
13-C mnr data compares favourably to literature 187 





Ethyl 7-chiorocarbonyl heptanoate (79) 
Cl 
0 
79 was prepared via the general procedure (J1)p.89) using oxalyl chloride (1.269g, lOmmol), 
monoethyl octanedioic acid (1.01 ig, 5mmol) and dry DCM (10cm)in a yield of 925mg 
(91%). bpo4mm = 100°C(Lit bP0imm = 78-80°C 188);  M 220.57075 (C91-1 15030 requires 
220.57084); 8H (200MHz, CDC13): 1.34 (3H, t, J=7.0 2'-CH3); 1.45 (4H, m, 4,5-CH2); 1.78 
(414, 3,6-CH2); 2.38 (214, t, J=7.2, 2-CH2); 2.98 (2H, t, J=7.2, 7-CH2); 4.21 (214, q, J=7.2, 
l'-CH2) oc (200MHz, CDC13): 14.6 (C-2'), 24.0 (C-4), 24.3 (C-5), 27.2 (C-3), 27.7 (C-6), 
33.7 (C-7),46.7 (C-2), 59.9 (C-l'), 173.5 (C-i), 173.9 (C-8). All 13-C nmr data compares 
favourably to literature  189 .  
Aldehyde Synthesis - General Procedure 167 
Bu3SnH (1.1 equivalents) was added drop-wise to a stirred solution of acid chloride and 
(Ph3P)4Pd (0.001 equivalents) in dry THF. The reaction mixture was stirred for lh before 
addition of hexane (10cm) and filtration of the precipitate. Evaporation and distillation 
afforded the required aldehyde. 
Ethyl 7-oxoheptanoate (64) 
64 was prepared using the general procedure (pp.89) with Bu 3SnH (1.164g. 4.Ommol), ethyl 
6-chlorocarbonyihexanoate (744mg, 3.6mmol) and (Ph 3P)4Pd (42mg, 36p.mol) in dry THF 
(7cm) in a yield of 459mg (74%). For data see Ethyl 7-oxoheptanoate (64) via Oxidation of 
66 pp.87  bp0 .02 = 79°C. 
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Ethyl 4-oxo butanoate (80) 
H 
80 was prepared by means of the general procedure (pp.89) using Bu 3SnH (2.241g, 
7. 7mmol) ethyl succinyl chloride (1.152mg, 7mmol) and (Ph 3P)4Pd (81mg, 70jimol) in dry 
THF (10cm) in a yield of 725mg (80%). bp 0.02mm = 60°C; M 130.063 10 (C 6141003 requires 
130.06303); 5H  (200MHiz, CDC13): 1.32 (311, t, J=7.2, 2'-CH2); 2.67 (2H, t, J=7.2, 2-CH2); 
2.85(2H, t, J=6.1, 3-CH2); 4.20 (211, q, J=7.2, 1'-CFI2); 9.87 (114, s,4-Cl); 8 c (200N1Hz, 
CDC13): 14.6 (C-2'), 28.3 (C-2), 43.5 (C-3), 60.9 (C- 1'), 173.5 (C- 1)202.5 (C-4) 
Methyl 6-oxo hexanoate (81) 
H 
81 was prepared according to the general procedure (pp. 89) with Bu 3SnH (2.241g. 7.7nimol) 
methyl 5-chiorocarbonyl pentanoate (78,1.250g. 7mmol) and (Ph 3P)4Pd (81mg, 70p.mol) in 
dry THF (7cm) in a yield of 853mg (83%). bp0.02mm 65°C; M 144.07875 (C7H1403 
requires 144.07869); oH (200MHz, CDC13): 1.39 (214, m, 3-CH2); 1.48 (214, m, 4-CH2); 1.71 
(2H, t, J=7.6, 2-CH2); 2.38 (2H, t, J=7.4, 5-CH2); 3.72 (314, s, 1'-CH 3); 9.83 (1H, s, 6-CH); 
Oc (200MHz, CDC13): 24.1 (C-3), 24.4 (C-4), 28.3 (C-2), 43.5 (C-5), 60.1 (C- l'), 173.5 (C-
1) 202.5 (C-6). 
Ethyl 8-oxo octanoate (70) 
H 
70 was prepared in the manner of the general procedure (pp.89) using Bu 3SnH (1.339g. 
4.6mmol), ethyl 7-chiorocarbonyl heptanoate (79, 929mg, 4.2mmol) and (Ph 3P)4Pd (49mg, 
42mol) and dry THF (8cm3)in a yield of 679mg (87%). For data see Ethyl 8-oxooctanoate 
(70) via Oxidation of 67 pp.87; bpo.02mm" 95°C. 
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Nitroalcohol Synthesis - General Procedure 171 
Nitromethane or nitroethane (2 equivalents) and powdered KOH (0.1 equivalents) were 
stirred in 'PrOH (10cm) for 0.5h and aldehyde in 'PrOH (3cm) added. The reaction mixture 
was stirred for 6h, Et20 (10cm) added and the resulting precipitate filtered through a pad of 
Celite (ig). Evaporation and purification by silica gel chromatography (20g, hexane/EtOAc, 
3:2) gave the desired nitroalcohol. 
Ethyl 7-hydroxy-8-nitro nonanoate (82) 
0 	 OH 
NO2 
82 was prepared in line with the general procedure (pp. 93) using nitroethane (2 10mg, 
2.8mmol), powdered KOH (8mg, 0. 14mmol) and ethyl 7-oxoheptanoate (64, 245mg, 
1.4mmol)in ayield of 330mg (95%). M 247.14201 (C 11 H21N05 requires 247.14197); 611 
(200MHz, CDC13): 1.23 (3H, t, J=7.0, 2'-CH3); 1.37 (6H, m, 3,4,5-CH2); 1.52 (3H, d, J=6.6, 
9-CH3); 1.62 (2H, n 6-CH2); 2.28 (2H, t, J=7.3, 2-CH2); 3.87, (1H, m, 7-CH); 4.09 (2H, q, 
J=7.1, 1'-CH2); 4.51 (1H, m, 8-CH2); 6c  (200MHz, CDCI3): 12.3 (C-9), 14.1 (C-2'), 24.1 
(C-4), 28.6, 28.7 (C-3, -5), 33.6, 33.9 (C-2, -6), 60.2 (C-l'), 71.8 (C-8), 86.2 (C-7), 173.6 (C-
1) 




83 was synthesised by means of the general procedure (pp.93) using nitroethane (600mg, 
8.Ommol), powdered KOH (22mg, 0.4mmol) and ethyl 4-oxo butanoate (80, 520mg, 
4.Ommol) in a yield of 722mg (88%). M 205.09510 (C 8H15N05 requires 205.09502); 611 
(200MHz, CDCI3): 1.33 (3H, t, J=7.0, 2'-CH3); 1.63 (3H, d, J=6.6, 6-CH3); 1.80 (2H, m, 3-
CH2); 2.59 (2H, t, J=7.0, 2-CH2); 4.05 (1H, m, 4-CHOH); 4.21 (2H, q, J=7.0, 1'-CH2); 4.60 
(2H, m, 5-CH); 6c  (200MHz, CDC13): 12.6 (C-6), 14.4 (C2'), 33.2, 34.0 (C-2, 3), 60.0 (C-
F), 71.5 (C-5), 86.7 (C-4), 173.2 (C- 1) 





Methyl 6-hydroxy-7-nitro octanoate (84) 
NO2 
OH 
84 was prepared in line with the general procedure (pp.93) using nitroethane (375mg, 
5.Ommol), powdered KOH (14mg, 0.3mmol) and methyl 6-oxo hexanoate (81, 359mg, 
2.5mmol)in a yield of 489mg (89%). M 219.11059 (C 9H17N05 requires 219.11067); oH 
(200MHz, CDC13): 1.49 (4H, m, 3,4-CH2); 1.61 (3H, d, J=7.0, 8-CH3); 1.67 (2H, m, 5-Cu2); 
2.38 (21-, t,J=7.2, 2-CH 2); 3.73 (3H, s, 1'-CH3); 4.24 (1H, m, 6-CH); 4.59 (1H, m, 7-CH); 
Oc (200MHz, CDC13): 12.0 (C-8), 28.5, 28.7 (C-3, -4), 33.5, 33.8 (C-2, -5), 58.7 (C-l'), 71.8 
(C-7), 86.2 (C-6), 173.9 (C- 1) 
Ethyl 8-hydroxy-9-nitro decanoate (85) 
NO2 
OH 
85 was prepared in accordance with the general procedure (pp. 93) using nitroethane (135mg, 
1. 8nunol),  powdered KOH (5mg, 0.09mmol) and ethyl 8-oxo octanoate (70, 169mg, 
0.9mmoi), in a yield of 164mg (70%). M 261.15753 (C 12H23N05 requires 261.15762); 0H 
(200MHz, CDC1 3): 1.32 (3H, t, J=7.0, 2'-CH3); 1.41 (4H, m, 4,5-CH 2); 1.62 (3H, d, J=6.6, 
10-CH3); 1.67 (4H, m, 3,6-CH 2); 1.81 (21-, m, 7-CH 2); 2.36 (2H, t, J=7.0, 2-CH2); 4.18 (211, 
q, J=7.2, 1'-CH2); 4.54 (211, m, 8,9-CH); Oc  (200MHz, CDC13): 12.0 (C- 10), 14.4 (C-2'), 
24.3 (C-4, -5), 28.4, 28.8 (C-3, -6), 33.4, 33.7 (C-2, -7), 60.2 (C- l'), 71.8 (C-9), 86.2 (C-8), 
173.2 (C-i) 





Ethyl 7-hydroxy-8-nitro octanoate (86) 
0 	 OH 
86 was prepared according to the general procedure (pp. 93) using nitromethane (17 1mg, 
2.8mmol), powdered KOH (8mg, 0. 14mmol) and ethyl 7-oxoheptanoate (64, 245mg, 
1.4mmol) in a yield of 301mg (92%). M 247.14201 (C 10H19N05 requires 233.12632);5H 
(200MHz, CDC1 3): 1.13(3H, t, J=7.0, 2'-CH3); 1.34 (2H, in, 4-CH2); 1.57 (4H, in, 3,5-CH2); 
1.84 (2H, m, 6-CH2); 2.52 (2H, t, J=7.4, 2-CH2); 4.32 (2H, q, J=7.2, 1'-CH2); 4.55 (3H, in, 
8-CH2, 7-CH); 8c (200MHz, CDC13): 14.4 (C-2'), 24.5 (C-4), 28.2, 28.4 (C-3, -5), 33.5, 33.6 
(C-2,-6),60.9 (C-l'), 71.1 (C-8), 85.4 (C-7),174.0 (C-i) 
Ethyl 4-hyd roxy-5-n itro pentanoate (87) 
87 was prepared in a similar manner to the general procedure (pp.93) using nitromethane 
(244mg, 4.Ommol), powdered KOH (11mg, 0.2mmol) and ethyl 4-oxo butanoate (80, 
245mg, 1.4mmol) ma yield of 345mg (90%). M 191.07942 (C7H 13N05 requires 191.07937); 
H (200MHz, CDC13): 1.33 (3H, t, J=7.0, 2'-CH3); 1.90 (2H, m, 3-CH2); 2.60 (2H, t, J=7.0, 
2-CH2); 3.34 (iH, m, 4-CH); 4.21 (2H, q, .1=7.2, 1'-CH 2); 4.48 (2H, m, 5-CH2); 8c  
(200MHz, CDC13): 14.3 (C-2'), 33.1, 33.6 (C-2, -3), 61.4 (C- F), 70.9 (C-5), 85.8 (C-4), 
173.8 (C-i) 
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Methyl 6-hydroxy-7-nitro heptanoate (88) 
OH 
88 was synthesised according to the general procedure (J)p.93) using nitromethane (3 05mg, 
5.Ommol), powdered KOH (14mg, 0.3mmol) and methyl 6-oxo hexanoate (81, 305mg, 
2.5mmol) in a yield of4l4mg (86%). M 205.09513 (C 8H15N05 requires 205.09502); 8H 
(200MHz, CDC13): 1.58 (4H, m, 3,4-CH2); 1.71 (2H, m, 5-CH2); 2.41 (2H, t, J=7.0, 2-CH2); 
3.73 (3H, s, 1'-CH3); 4.78 (311, m, 7-CH2, 6-CH); 8c (200MHz, CDC13): 28.3, 28.6 (C-3, -4), 
33.2, 33.5 (C-2, -5), 59.3 (C- F), 71.6 (C-7), 86.5 (C-6), 173.8 (C- 1) 
Ethyl 8-hydroxy-9-nitro nonanoate (89) 
NO2 
OH 
89 was prepared in a similar manner to the general procedure (pp.93) using nitromethane 
(110mg, 1.8mmol), powdered KOH (5mg, 0.09mmol) and ethyl 8-oxo octanoate (70, 
245mg, 1.4mmol)in ayield of 183mg (82%). M 247.14978 (C 11 H21N05 requires 
247.14969); 5H  (200MHz, CDC13): 1.32(3H, t, J=7.0, 2'-CH3); 1.39 (4H, m, 4,5-CH2); 1.67 
(611, m, 3,6,7-CH2); 2.35 (211, t, J=7.4, 2-CH2); 4.18 (211, q, J=7.0, 1 '-CH2); 4.55 (3H, m 9-
CH2, 8-CH); 8c (200MHz, CDC13): 14.1 (C-2'), 24.5, 24.8 (C4, -5), 28.5, 28.7 (C-3, -6), 
33.4, 33.7 (C-2, -7), 60.9 (C- F), 70.8 (C-9), 85.1 (C-8), 173.8 (C- 1) 
Nitroketone Synthesis - General Procedure 
Jones Reagent (1 volume equivalent) was added solution of mtroalcohol in acetone (3cm). 
The reaction mixture was stirred at 15°C for lh, warmed to room temperature and the 
chromium salts filtered through Ceite. Et 20 (5 cm) was added to the filtrate and the solution 
washed with HC1 (0. 1M, 3x5cm) and brine (5cm3) before evaporation. The resultant oil was 
purified by silica gel chromatography to yield the desired nitroketone. 
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Ethyl 8-nitro-7-oxo nonanoate (90) 
NO2 
90 was prepared in accordance with the general procedure (pp.96) using ethyl 7-hydroxy-8-
nitro nonanoate (82, 173mg, 0.7mmol) and Jones' Reagent (0.7cm) in acetone (4cm 3) in a 
yield of 155mg (91%). M 245.12645 (C11H19N05 requires 245.12632); 8H  (200MHz, 
CDC13): 1.19 (31-1, t, J=7.1, 2'-CI-13); 1.30 (2H, m, 4-Cl-I2); 1.54 (41-1, m, 3,5-CH 2); 1.65 (3H, 
d, J=7.0, 9-CH3); 2.27 (2H, t, J=7.1, 6-CH2); 2.53 (214, t, J=6.8, 2-CH2); 4.06 (2H, q, J=7.2, 
l'-CH2); 5.18 (11-1, q, J=7.1, 8-CH); 8 c (20OMBz, CDC13): 11.9(C-9), 14.3 (C-2'), 24.6(C- 
4), 28.4, 28.7 (C-3, -5), 33.2, 33.4 (C-2, -6), 60.7 (C-l'), 71.7 (C-8), 173.4 (C-i), 179.6 (C-7) 




91 was prepared in accordance with the general procedure (pp.96) using ethyl 4-hydroxy-5-
nitro hexanoate (83, 308mg, 1.5mmol) and Jones Reagent (1.5cm 3) in acetone (10cm 3) in a 
yield of 271mg (89 1/o). M 203.07929 (C8H13N05 requires 203.07937); 6H  (200MHz, 
CDC13): 1.14 (311, t, J=7.2, 2'-CH3); 1.66 (3H, d, J6.6, 6-CH3); 2.25 (21-1, t, J=7.2, 3-CH2); 
2.52 (2H, t, J=7.4, 2-CH2); 5.21 (11-1, q, J=7.2, 5-CH); öc (200MHz, CDC1 3): 12.7 (C-6), 
14.3 (C-2'), 33.4, 33.9 (C-2, -3), 60.2 (C- F), 71.6 (C-5), 173.1 (C- 1), 179.4 (C-4) 
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Methyl 7-n itro-6-oxo octanoate (92) 
NO2 
92 was prepared via the general procedure (pp.96) using methyl 6-hydroxy-7-nitro octanoate 
(84, 263mg, 1 .2mmol) and Jones Reagent (1.2cm 3) in acetone (10cm) in a yield of 228mg 
(88%). M217.09511 (C914 15N05 requires 217.09502); 8H  (200MHz, CDC13): 1.76 (41-1, m, 
3,4-CH2); 1.79 (311, ci, J'7.4, 8-CH3); 2.46 (211, t, J=6.6, 2-CH2); 2.70 (211, t, J=6.4, 5-CH2); 
3.73 (311, s, 1 '-CH3); 5.31 (111, q, J7.0, 7-CH); c  (200MHz, CDCI3): 12.2 (C-8),28.4,28.8 
(C-3,-4),33.6,33.9(C-2,-5), 58.9 (C-l'), 71.9 (C-7),173.8 (C-i), 179.9(C-7) 
Ethyl 9-nitro-8-oxo decanoate (93) 
93 was prepared in an analogous manner to the general procedure (pp.96) using ethyl 8-
hydroxy-9-nitro decanoate (85, 183mg, 0.7mmol) and Jones Reagent (0.7cm 3) in acetone 
(4cm) in a yield of 158mg (87%). M 259. 14205 (C 12H21N05 requires 259.14197); 8H 
(200MIHz, CDC1 3):): 1.32(3H, t, J=7.0, 2'-CH3); 1.41 (4H, m, 4,5-CH2); 1.70 (41-, m, 3,6-
CH2); 1.78 (311, ci, J=7.4, 10-CH3); 2.42 (211, t, J=7.4, 2-CH2); 2.64 (2H, t, J=7.4, 7-CH2); 
4.18 (211, q, J=7.0, 1'-CH2); 5.31 (11-1, q, J=7.0, 9-CH); öc (200MHz, CDC1 3): 12.2 (C- 10), 
14.5 (C-2'), 24.2, 24.6 (C-4, -5), 28.3, 28.8 (C-3, -6), 33.3, 33.5 (C-2, -7), 60.4 (C-l'), 71.4 
(C-9), 173.4 (C- 1), 179.8 (C-8). 
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Ethyl 8-nitro-7-oxo octanoate (94) 
NO2 
94 was prepared in line with the general procedure (pp.96) using Jones Reagent (0.6cm 3) and 
ethyl 7-hydroxy-8-nitro octanoate (86, 150mg, 0.6mmol) in acetone (3cm) in a yield of 
130mg(94%). M 247. 14201 (C 10H17N05 requires 231.11067); 5H(200M1-IZ, CDC13): 
1. 13(3H, t, J=7.0, 2'-CH3); 1.45 (2H, m, 4-CH2); 1.68 (4H, in, 3,5-CH2); 2.37 (211, t, J=7.2, 
2-Cl-I2); 2.61 (2H, t, J=7.0, 6-CH 2); 4.32 (2H, q, J=7.2, 1'-CH2); 5.35 (2H, s, 8-CH2); 8c  
(200MHz, CDC13): 14.4 (C-2'), 24.5 (C-4), 28.2, 28.4 (C-3, -5), 33.5, 33.6 (C-2, -6), 60.9 
(C- l'), 71.1 (C-8), 174.0 (C- 1), 179.9 (C-7) 
Ethyl 5-nitro-4-oxo penta noate (95) 
"-'o 	
NO2 
95 was prepared in a similar manner the general procedure (pp.96) using Jones Reagent 
(0.9cm) and ethyl 4-hydroxy-5-nitro pentanoate (87, 172mg, 0.9mmol) in acetone (5cm 3) in 
a yield of 158mg(93%). M 189.06380 (C7H11N05 requires 189.06372); 6H  (200MHz, 
CDC13):): 1.11 (3H, t, J=7.2, 2'-CH3); 2.45 (4H, in, 2-CH2); 4.29 (2H, q, J=7.0, 1'-CH2); 
4.49 (31-L m, 5-CH2); 6c  (200MHz, CDC1 3): 14.1 (C-2'), 33.2, 33.5 (C-2, -3), 61.6 (C- l'), 
71.3 (C-5), 174.3 (C-i), 180.2 (C-7) 
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Methyl 7-n itro-.6-oxo hepta noate (96) 
NO2 
96 was prepared by means of the general procedure (pp.96) using Jones Reagent (1.2cm 3) 
and ethyl 6-hydroxy-7-nitro heptanoate (88, 246mg, 1 .2mmol) in acetone (15cm3) in a yield 
of 222mg (91%). M 203.07945 (C 8H13N05 requires 203.07937); oH (200MHz, CDC13): 
1.15 (3H, s, J=7.0, 2'-CH 3); 1.34 (41-1, m, 3,4-CH 2); 2.19 (21-1, t, J=7.3, 2-CH2); 2.51 (2H, t, 
J=7.2, 5-CH2); 3.69 (31-1, s, 1'-CH 3); 4.59 (214, m, 7-CH2); 0c  (200M11-Iz, CDC13): 28.4, 28.7 
(C-3, -4), 33.1, 33.5 (C-2, -5), 58.9 (C-l'), 70.2 (C-7),174.0 (C-i), 179.7 (C-6) 
Ethyl 9-nitro-8-oxo nonanoate (97) 
97 was prepared in accordance to the general procedure (pp.96) using Jones Reagent 
(CrO3I1-12SO4, 0.6cm3) and ethyl 8-hydroxy-9-nitro nonanoate (89, 148mg, 0.6mmol) in 
acetone (10cm3)in a yield of 132mg (90%). M 245.12622 (C 1 1 H19N05 requires 245.12632); 
0H (200MHz, CDC13): 1.29 (31-1, t, J=7.2, 2'-CH3); 1.39 (41-1, m, 4,5-CH2); 1.68 (4H, m, 3,6-
CH2); 2.34 (21-1, t, J7.2, 2-CH2); 2.59 (2H, t, J=7.2, 7-CH2); 4.16 (21-1, q, J=7.0, 1 '-CH2); 
5.34 (2H, s, 9-CH2); Oc  (200MHz, CDC13): 13.9 (C-2'), 24.2, 24.6 (C-4, -5), 28.6, 28.9 (C-3, 
-6), 33.4, 33.6 (C-2, -7), 61.4 (C- F), 70.9 (C-9), 174.0 (C- 1), 179.6 (C-8) 





Aminoalcohol and Aminoketone Synthesis - General 
Procedure 184 
Nitroalcohol or mtroketone (0.5mmol) in EtOHJc.HC1 (20:1, 1cm) was added drop-wise to a 
suspension of Pt-S-C (10%, 10mg) in EtOHIc.HC1 (20:1, 2cm) and hydrogenated at 50°C 
for 16h. The solution was filtered, washed with MeOH (3cm 3), and the filtrate evaporated 
under reduced pressure. The residue was dissolved in aqHCl (SM, 5cm3), stirred at 50°C for 
4h and evaporated to dryness. Purification by ion exchange chromatography (DOWEX-50, 
H form, eluting with HC1, 0-1M) gave the desired aminoalcohol or aminoketone as its HC1 
salt. 
8-Amino-7-oxo-nonanoic acid (8) 
NHcr 
8 was prepared in accordance with the general procedure (pp.101) using ethyl 8-nitro-7-oxo 
octanoate (123mg, 0.5mmol) in a yield of 55mg (58%). Rf= 0.46 (butanollacetic acid/water, 
3:1:1), M+1(ESI +ve): 188.3 (C 9H17NO3 requires 187.2); for other data see 8-Amino-7-oxo-
nonanoate hydrochloride (8), pp. 79 
5-Amino-4-oxo hexanoate (98) 
NC1 
98 was prepared in keeping with the general procedure (pp.101) using ethyl 5-mtro-4-oxo 
octanoate (90, 102mg, 0.5mmol) in a yield of 55mg (60%). Rf= 0.48 (butanollacetic 
acid/water, 3:1:1), MH: 146.08 164 (C 6H12NO3 requires 146.08172); 5H  (200MHz,D20): 
1.47 (311, d, J=7.2, 6-CH3); 2.59 (4H, m, 2,3-CH2); 4.21 (1H, q, J=6.9, 5-CH); 8c (250MHz, 
D20): 14.2 (C-6), 33.6 (C-2), 37.4 (C-3), 54.9 (C-5), 179.5 (C-i), 209.8 (C-4) 
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7-Amino-6-oxo octanoate (99) 
99 was prepared in the same way as the general procedure (pp. 10 1) using ethyl 7-nitro-6-
oxooctanoate (91, 109mg, 0.5mmol) in a yield of 67mg (64%). Rf= 0.45 (butanollacetic 
acid/water, 3:1:1), MH+: 174.11313 (C8H16NO3 requires 174.11302); 0H(200MHz,D20): 
1.43 (3H d, J=7.4, 8-CH3); 1.51 (4H, m, 3,4-CH2); 2.29 (414, t, J7.2, 2,5-CH2); 4.15 (111, 
q, J7.3, 7-CH); DC (250MHz, D20): 14.9 (C-8), 23.7, 27.6 (C-3, -4) 33.3 (C-2), 37.9 (C-




100 was prepared in an analogous manner to the general procedure (pp. 10 1) using ethyl 9-
nitro-8-oxodecanoate (92, 105mg, 0.4mmol) in a yield of 54mg (57%). Rf= 0.41 
(butanollacetic acid/water, 3:1:1), MH: 202.14441 (C 10H20NO3 requires 202.14432); 8H 
(200MIHz,D20): 1.41 (314, d, J=7.4, 10-CH3); 1.49 (414, m, 3,6-CH2); 1.77 (414, m, 4,5-CH 2); 
2.55 (4H, m, 2,7-CH2); 4.19 (11-1, q, J=7.1, 9-CH); 8c (250MHz, D20): 14.5 (C-b), 22.6, 
23.5, 27.8,28.1 (C-3, -4, -5, -6) 33.6 (C-2), 38.0 (C-7), 54.8 (C-9),178.7 (C-i), 208.9 (C-8) 
8-Amino-7-oxo octanoic acid (101) 
NIICI 
101 was prepared in keeping with the general procedure (pp.101) using ethyl 8-nitro-7-oxo 
octanoate (93, 116mg, 0.5mmol) in a yield of 67mg (67%). Rf= 0.44 (butanollacetic 
acid/water, 3:1:1), MH: 174.113 10 (C 81416NO3 requires 174.11302); 8H  (200M}iz,D20): 
1.00 (2H, m, 4-CH2); 1.29 (414, m, 3,5-CH 2); 2.07 (21-L t, J=7.1, 2-CH2); 2.29 (214, t, J=73, 
6-CH2); 3.83 (21-1, s, 8-CH2); 5c (250MHz, D20): 22.5, 23.7, 27.2 (C-3, -4, -5) 33.3 (C-2), 
37.1 (C-6), 54.2 (C-8), 178.7 (C- 1), 209.5 (C-7) 
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5-Amino-4-oxo pentanoate (102) 
-bll~ NIt3CI 
102 was prepared in a analogous manner to the general procedure (pp.10!) using ethyl 5-
nilro-4-oxo pentanoate (94, 95mg, 0.5mmol) in a yield of 59mg (70%). Rf= 0.47 
(butanollacetic acid/water, 3:1:1); MH: 132.06615 (C 5H10NO3 requires 132 . 06607);H 
(200MRz,D20): 2.58 (2H, t, J=5.6, 2-CH2); 2.75 (214, t, J=7.4, 3-Cl-I2); 3.99 (2H, s, 5-CU2); 
8c (250M}{z, D20): 33.2 (C-2), 37.1 (C-3), 54.7 (C-5), 179.4 (C-i), 209.2 (C-4) 
7-Amino-6-oxo heptanoate (103) 
+ — 
NC1 
103 was prepared in keeping with the general procedure (pp.101) using ethyl 7-nitro-6-
oxoheptanoate (95, 102mg, 0.5mmol) in a yield of6lmg (62%). Rf= 0.44 (butanollacetic 
acid/water, 3:1:1), MH: 160.09746 (C 71-1 14NO3 requires 160.09737); 8H  (200MHz,D20): 
1.17 (414, m, 3,4-Cl-I 2); 2.28 (414, t, J=6.4, 2,5-CU2); 4.04 (214, s, 7-CU2); öc (250MBz, 
D20): 23.8, 27.8 (C-3, -4) 33.3 (C-2), 37.3 (C-5), 54.2 (C-7), 179.7 (C-!), 209.3 (C-6) 
9-Amino-8-oxononanoate (104) 
N Ft, C1 
104 was prepared in an identical method to the general procedure (pp.101) using ethyl 9-
nitro-8-oxononanoate (96, 123mg, 0.5mmol) in a yield of 66mg (59%). Rf = 0.40 
(butanollacetic acid/water, 3:1:1), MH: 188.12875 (C 9H18NO3 requires 188.12867); SH 
(200M1-Iz,D20): 1.22 (21-1, m, 4,5-CU2); 1.49 (414, m, 3,6-CH2); 2.27 (21-1, t, J=7.3, 2-CH2); 
2.50 (21-I, t, J=7.3, 7-CU2); 3.96 (214, s, 9-CH2); 5c (250MHz, D20): 22.5, 23.4, 27.8, 28.3 
(C-3, -4, -5, -6) 33.9 (C-2), 37.8 (C-7), 54.8 (C-9), 179.0 (C- 1), 209.3 (C-8) 
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8-Amino-7-hydroxy nonanoic acid (105) 
	




105 was prepared in line with the general procedure (pp. 10 1) using ethyl 7-hydroxy-8-nitro 
nonanoate (82, 124mg, 0.5mmol) in a yield of 78mg (69%). Rf= 0.31 (butanollacetic 
acid/water, 3:1:1), M}f: 190.14443 (C 9H20NO3 requires 190.14432); 8H (200MHz,D 20): 
1.33 (2H m, 4-CH2); 1.44 (3H, d, J=7.4, 9-CH3); 1.61 (4H, m, 3,5-CH 2); 1.96 (21-L m, 6-
CH2); 2.32 (211, t, J=7.4, 2-CH2); 4.29 (2H, m, 7,8-CH); 5c (250MHz, D20): 14.6 (C-9), 
22.2, 23.9, 27.5 (C-3, -4, -5) 33.7 (C-2), 37.8 (C-6), 54.8 (C-8), 86.4 (C-7), 179.0 (C-i), 




106 was prepared in a equivalent method to the general procedure (pp. 10 1) using ethyl 4-
hydroxy-5-nitro hexanoate (83, 103mg, 0.5mmol) in a yield of 58mg (63%). Rf= 0.33 
(butanollacetic acid/water, 3:1:1), MH: 148.09742 (C 6H14NO3 requires 148.09737); 5H 
(200MHz,D20): 1.50 (314, d, J=6.9, 6-CH3); 2.61 (4H, m, 2,3-CH 2); 4.25 (2H, m, 4,5-CH); 
c (250MHz, D20): 14.2 (C-6), 33.6 (C-2), 37.4 (C-3), 54.9 (C-5), 86.3 (C-4),179.5 (C-i). 
7-Amino-6-hydroxy octanoate (107) 
OH 
107 was prepared in line with the general procedure (pp.101) using ethyl 6-hydroxy-7-
nitrooctanoate (84, 110mg, 0.5mmol) in a yield of 69mg (65%). Rf= 0.32 (butanollacetic 
acid/water, 3:1:1), MH: 176. 12877 (C8H 18NO3 requires 176.12867); 8H  (200MHz,D20): 
1.41 (3H, d, J=7.0, 8-CH3); 1.55 (411, m, 3,4-CH2); 1.79 (2H, m, 6-C112); 2.55 (2H, t, J=7.4, 
2-CH2); 4.33 (2H, m, 6,7-CH); 8 c (250MHz, D20): 14.9 (C-8),23.7,27.6 (C-3, -4) 33.3 (C-
2), 37.9 (C-5), 54.6 (C-7), 85.9 (C-6), 179.0 (C-i). 
Mhairi I. Brunton 	 October 2002 
104 






108 was prepared in a comparable manner to the general procedure (pp.101) using ethyl 8-
hydroxy-9-nitrodecanoate (85, 105mg, 0.4mmoi) in a yield of 57mg (59%). Rf =0.29 
(butanollacetic acid/water, 3:1:1), MW: 204.15989 (C 10HNO3 requires 204.15997); 8 H 
(200MHz,D20): 1.32 (4H, in, 4,5-CH2); 1.45 (3H, d, J=6.8, 10-CH3); 1.55 (41-, in, 3,6-CH2); 
1.77 (2H, m, 7-CH2); 2.56 (2H, t, J=7.3, 2-CH2); 4.33 (2H, m, 8,9-CH); 8c (250MHz, D20): 
14.5 (C-b), 22.6, 23.5, 27.8, 28.1 (C-3, -4, -5, -6) 33.6 (C-2), 38.0 (C-7), 54.8 (C-9), 86.8 
(C-8), 178.7 (C-i) 
8-Amino-7-hydroxy octanoate (109) 
0 	 OH 
0)~ 
NECi 
109 was prepared according to the general procedure (pp.101) using ethyl 7-hydroxy-8-nitro 
octanoate (86, 117mg, 0.5mmoi) in a yield of 72mg (68%). Rf= 0.25 (butanollacetic 
acid/water, 3:1:1), NM' : 176.12854 (C8H18NO3 requires 176.12867); öu (200MHz,D 20): 
1.32 (214, m, 4-Cl-I2); 1.54 (4H, in, 3,5-CH2); 1.89 (2H, in, 6-CH2); 2.25 (211, t, J=7.3, 2-
CH2); 4.49 (3H, m, 8-CH2, 7-CH); 6c  (250MHz, D20): 22.5, 23.7, 27.2 (C-3, -4, -5) 33.3 (C- 
2), 37.1 (C-6), 54.2 (C-8), 86.3 (C-7), 178.7 (C- 1). 
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5-Amino-4-hydroxy pentanoate (110) 
Nl-tCI 
OH 
110 was prepared in a similar manner to the general procedure (pp.10!) using ethyl 4-
hydroxy-5-mtro pentanoate (87, 100mg, 0.5mmol) in a yield of 54mg (64%). Rf= 0.28 
(butanollacetic acid/water, 3:1:1), MIH: 134.08165 (C5H12NO3 requires 134.08172); 5H 
(200MHz,D20): 1.92 (2H, m, 3-CH 2); 2.29 (2H, t, J=7.0, 2-CU2); 4.29 (2H, m, 4-CH, 5-
CU2) ; 8c (250MHz, D20): 33.2 (C-2), 37.1 (C-3), 54.7 (C-5), 86.7 (C-4), 179.4 (C-i). 
7-Amino-6-hydroxy heptanoate (I 11) 
NC1 
OH 
111 was prepared in accordance with the general procedure (pp.101) using ethyl 6-hydroxy-
7-nitro heptanoate (88, 103mg, 0.5mmol) in a yield of 57mg (58%). Rf= 0.24 
(butanollacetic acid/water, 3:1:1), MH: 162.11295 (C 71-1 16NO3 requires 162.11302); 8H 
(200MHz,D20): 1.54 (414, m, 3,4-CH2); 1.76 (21-1, m, 5-CU 2); 2.27 (2H, t, J=7.1, 2-CH2); 
4.78 (31-, m, 6-04, 7-CH2); 8c (250MHz, D20): 23.8, 27.8 (C-3, -4) 33.3 (C-2), 37.3 (C-5), 
54.2 (C-7), 85.7 (C-6), 179.7 (C- 1), 
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112 was prepared in a similar manner as the general procedure (pp. 101) using ethyl 8-
hydroxy-9-nitrooctanoate (89, 124mg, 0.5mmol) in a yield of 69mg (61%). Rf= 0.29 
(butanollacetic acid/water, 3:1:1), Mif: 190. 14439 (C 9H20NO3 requires 190.14432); oH 
(200M1-Iz,D20): 1.35 (4H, in, 4,5-CH2); 1.70 (6H, in, 3,6,7-CH2); 2.31 (2H, t' J=7.1, 2-CH2); 
4.41 (31-i, m, 8-CIT. 9-CH 2); 0c  (250M1{z, D20): 22.5, 23.4, 27.8, 28.3 (C-3, -4, -5, -6) 33.9 
(C-2), 37.8 (C-7), 54.8 (C-9), 86.2 (C-8), 179.0 (C- 1), 209.3 (C-8) 
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